UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)
☒ QUARTERLY REPORT PURSUANT TO SECTION
13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 2023
OR
☐ TRANSITION REPORT PURSUANT TO SECTION
13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from
to .
Commission File Number 001-41321
PATRIA LATIN AMERICAN OPPORTUNITY ACQUISITION
CORP.
(Exact name of registrant as specified in its charter)
Cayman Islands | | N/A |
(State or other jurisdiction of
incorporation or organization) | | (I.R.S. Employer
Identification Number) |
18 Forum Lane, 3rd floor, Camana Bay, PO Box 757, Grand Cayman, KY1-9006 |
(Address of principal executive offices) |
+1 345 640 4900 |
Registrant’s Telephone Number, Including Area Code |
Securities registered pursuant to Section 12(b) of the Act: |
Title of Each Class | | Trading Symbol(s) | | Name of Each Exchange on Which Registered |
Units, each consisting of one Class A ordinary share, $0.0001 par value, and one-half of one redeemable warrant | | PLAOU | | The Nasdaq Stock Market LLC |
Class A ordinary shares, included as part of the units | | PLAO | | The Nasdaq Stock Market LLC |
Redeemable warrants, included as part of the units, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 | | PLAOW | | The Nasdaq Stock Market LLC |
Indicate by check mark whether the Registrant: (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter
period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes ☒ No ☐
Indicate by check mark whether the Registrant has submitted electronically
every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the
preceding 12 months (or for such shorter period that the Registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the Registrant is a large accelerated
filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions
of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging
growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer ☐ | Accelerated filer ☐ |
Non-accelerated filer ☒ | Smaller reporting company ☒ |
| Emerging growth company ☒ |
If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the Registrant is a shell company (as
defined in Rule 12b-2 of the Exchange Act). Yes ☒ No ☐
As of November 13, 2023, there were 16,880,481 Class A ordinary shares, par value
$0.0001 per share and 5,750,000 Class B ordinary shares, par value $0.0001 per share, issued and outstanding, respectively.
PATRIA
LATIN AMERICAN OPPORTUNITY ACQUISITION CORP.
table
of contents
PART I – FINANCIAL INFORMATION
Item 1. Condensed Financial Statements
PATRIA LATIN AMERICAN OPPORTUNITY ACQUISITION
CORP
CONDENSED BALANCE SHEETS
| |
September 30, 2023 (Unaudited) | | |
December 31, 2022 | |
| |
| | |
| |
ASSETS | |
| | |
| |
Cash | |
$ | 182,243 | | |
$ | 707,749 | |
Prepaid expenses | |
| 133,855 | | |
| 307,756 | |
Marketable securities held in Trust Account | |
| 183,950,121 | | |
| 240,311,986 | |
Total current assets | |
| 184,266,219 | | |
| 241,327,491 | |
Total Assets | |
$ | 184,266,219 | | |
$ | 241,327,491 | |
| |
| | | |
| | |
LIABILITIES, ORDINARY SHARES SUBJECT
TO POSSIBLE REDEMPTION, AND SHAREHOLDERS’ DEFICIT | |
| | | |
| | |
Current liabilities: | |
| | | |
| | |
Accounts payable | |
$ | 226,158 | | |
$ | — | |
Due to related party | |
| 1,200,000 | | |
| 3,144 | |
Accrued expenses | |
| 74,757 | | |
| 68,627 | |
Derivative warrant liabilities | |
| 1,560,000 | | |
| 2,340,000 | |
Deferred underwriting fees payable | |
| 8,050,000 | | |
| 8,050,000 | |
Total current liabilities | |
| 11,110,915 | | |
| 10,461,771 | |
Total liabilities | |
| 11,110,915 | | |
| 10,461,771 | |
| |
| | | |
| | |
Commitments and Contingencies (Note 6) | |
| | | |
| | |
Class A ordinary shares subject to possible redemption, $0.0001 par value; 16,880,481 and 23,000,000 shares at $10.90 and 10.45 per share at September 30, 2023 and December 31, 2022, respectively | |
| 183,950,121 | | |
| 240,311,986 | |
Shareholders’ deficit | |
| | | |
| | |
Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding | |
| — | | |
| — | |
Class A ordinary shares, $0.0001 par value; 200,000,000 shares authorized; none issued or outstanding (excluding 16,880,481 and 23,000,000 shares subject to possible redemption at September 30, 2023 and December 31, 2022, respectively) | |
| — | | |
| — | |
Class B ordinary shares, $0.0001 par value; 20,000,000 shares authorized; 5,750,000 shares issued and outstanding | |
| 575 | | |
| 575 | |
Additional paid-in capital | |
| — | | |
| — | |
Accumulated deficit | |
| (10,795,392 | ) | |
| (9,446,841 | ) |
Total shareholders’ deficit | |
| (10,794,817 | ) | |
| (9,446,266 | ) |
Total Liabilities, Ordinary Shares Subject to Possible Redemption, and Shareholders’ Deficit | |
$ | 184,266,219 | | |
$ | 241,327,491 | |
The accompanying notes are an integral part
of these unaudited condensed financial statements.
PATRIA LATIN AMERICAN OPPORTUNITY ACQUISITION
CORP
CONDENSED STATEMENTS OF OPERATIONS
(Unaudited)
| |
For the | | |
For the | | |
For the | | |
For the | |
| |
Three Months Ended | | |
Three Months Ended | | |
Nine Months Ended | | |
Nine Months Ended | |
| |
September 30, 2023 | | |
September 30, 2022 | | |
September 30, 2023 | | |
September 30, 2022 | |
General and administrative expenses | |
$ | 241,063 | | |
$ | 240,538 | | |
$ | 928,551 | | |
$ | 728,577 | |
Loss from operations | |
| (241,063 | ) | |
| (240,538 | ) | |
| (928,551 | ) | |
| (728,577 | ) |
Change in fair value of derivative warrant liabilities | |
| (353,600 | ) | |
| (1,300,000 | ) | |
| 780,000 | | |
| 4,720,500 | |
Realized gain on investments held in Trust Account | |
| 2,360,877 | | |
| 1,101,855 | | |
| 7,601,882 | | |
| 1,403,465 | |
Transaction costs allocated to derivative warrant liabilities | |
| — | | |
| — | | |
| — | | |
| (314,508 | ) |
Net income | |
$ | 1,766,214 | | |
$ | (438,683 | ) | |
$ | 7,453,331 | | |
$ | 5,080,880 | |
Weighted average shares outstanding of Class A ordinary shares subject to possible redemption, basic and diluted | |
| 16,880,481 | | |
| 23,000,000 | | |
| 20,511,844 | | |
| 16,934,066 | |
Basic and diluted net income per share, Class A ordinary shares subject to possible redemption | |
$ | 0.13 | | |
$ | (0.01 | ) | |
$ | 0.38 | | |
$ | 0.65 | |
Weighted average shares outstanding of Class B non-redeemable ordinary shares, basic and diluted | |
| 5,750,000 | | |
| 5,750,000 | | |
| 5,750,000 | | |
| 5,552,198 | |
Basic and diluted net income (loss) per share, Class B non-redeemable ordinary shares | |
$ | (0.07 | ) | |
$ | (0.05 | ) | |
$ | (0.05 | ) | |
$ | (1.06 | ) |
The accompanying notes are an integral part
of these unaudited condensed financial statements.
PATRIA LATIN AMERICAN OPPORTUNITY ACQUISITION
CORP
CONDENSED STATEMENTS OF CHANGES IN ORDINARY SHARES SUBJECT TO POSSIBLE
REDEMPTION AND SHAREHOLDERS’ DEFICIT
FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2023
(Unaudited)
| |
Ordinary
Shares Subject to Possible Redemption | | |
Ordinary
Shares | | |
Additional | | |
| | |
Total | |
| |
Class
A | | |
Class
B | | |
Paid-In | | |
Accumulated | | |
Shareholders’ | |
| |
Shares | | |
Amount | | |
Shares | | |
Amount | | |
Capital | | |
Deficit | | |
Deficit | |
Balance as of January 1, 2023 | |
| 23,000,000 | | |
$ | 240,311,986 | | |
| 5,750,000 | | |
| 575 | | |
$ | - | | |
$ | (9,446,841 | ) | |
$ | (9,446,266 | ) |
Accretion of Class A ordinary shares to redemption value | |
| - | | |
| 2,569,175 | | |
| - | | |
| - | | |
| - | | |
| (2,569,175 | ) | |
| (2,569,175 | ) |
Net income | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| 2,278,938 | | |
| 2,278,938 | |
Balance as of March 31, 2023 (unaudited) | |
| 23,000,000 | | |
$ | 242,881,161 | | |
| 5,750,000 | | |
$ | 575 | | |
$ | - | | |
$ | (9,737,078 | ) | |
$ | (9,736,503 | ) |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Redemption of Class A ordinary shares | |
| (6,119,519 | ) | |
| (65,163,747 | ) | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | |
Accretion of Class A ordinary shares to redemption value | |
| - | | |
| 2,971,830 | | |
| - | | |
| - | | |
| - | | |
| (2,971,830 | ) | |
| (2,971,830 | ) |
Net income | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| 3,408,179 | | |
| 3,408,179 | |
Balance as of June 30, 2023 (unaudited) | |
| 16,880,481 | | |
$ | 180,689,244 | | |
| 5,750,000 | | |
$ | 575 | | |
$ | - | | |
$ | (9,300,729 | ) | |
$ | (9,300,154 | ) |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Accretion of Class A ordinary shares to redemption value | |
| - | | |
| 3,260,877 | | |
| - | | |
| - | | |
| - | | |
| (3,260,877 | ) | |
| (3,260,877 | ) |
Net income | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| 1,766,214 | | |
| 1,766,214 | |
Balance as of September 30, 2023 (unaudited) | |
| 16,880,481 | | |
$ | 183,950,121 | | |
| 5,750,000 | | |
$ | 575 | | |
$ | - | | |
$ | (10,795,392 | ) | |
$ | (10,794,817 | ) |
FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER
30, 2022
| |
Ordinary
Shares Subject to Possible Redemption | | |
Ordinary
Shares | | |
Additional | | |
| | |
Total | |
| |
Class
A | | |
Class
B | | |
Paid-In | | |
Accumulated | | |
Shareholders’ | |
| |
Shares | | |
Amount | | |
Shares | | |
Amount | | |
Capital | | |
Deficit | | |
Deficit | |
Balance as of January 1, 2022 | |
| - | | |
$ | - | | |
| 5,750,000 | | |
| 575 | | |
$ | 24,425 | | |
$ | (49,868 | ) | |
$ | (24,868 | ) |
Proceeds from the sale of Class A Units | |
| 23,000,000 | | |
| 230,000,000 | | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | |
Paid underwriters fees | |
| - | | |
| (4,600,000 | ) | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | |
Deferred underwriting fees payable | |
| - | | |
| (8,050,000 | ) | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | |
Liability-classified equity instruments - Public Warrants | |
| - | | |
| (4,151,500 | ) | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | |
Other offering costs | |
| - | | |
| (815,157 | ) | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | |
Excess cash received over fair value of Private Placement Warrants | |
| - | | |
| - | | |
| - | | |
| - | | |
| 9,251,000 | | |
| - | | |
| 9,251,000 | |
Accretion of Class A ordinary shares to redemption value | |
| - | | |
| 24,483,533 | | |
| - | | |
| - | | |
| (9,275,425 | ) | |
| (15,208,108 | ) | |
| (24,483,533 | ) |
Net loss | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| (829,640 | ) | |
| (829,640 | ) |
Balance as of March 31, 2022 (unaudited) | |
| 23,000,000 | | |
$ | 236,866,876 | | |
| 5,750,000 | | |
$ | 575 | | |
$ | - | | |
$ | (16,087,616 | ) | |
$ | (16,087,041 | ) |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Accretion of Class A ordinary shares to redemption value | |
| - | | |
| 334,734 | | |
| - | | |
| - | | |
| - | | |
| (334,734 | ) | |
| (334,734 | ) |
Net income | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| 6,349,203 | | |
| 6,349,203 | |
Balance as of June 30, 2022 (unaudited) | |
| 23,000,000 | | |
$ | 237,201,610 | | |
| 5,750,000 | | |
$ | 575 | | |
$ | - | | |
$ | (10,073,147 | ) | |
$ | (10,072,572 | ) |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Accretion of Class A ordinary shares to redemption value | |
| - | | |
| 1,101,855 | | |
| - | | |
| - | | |
| - | | |
| (1,101,855 | ) | |
| (1,101,855 | ) |
Net loss | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| (438,683 | ) | |
| (438,683 | ) |
Balance as of September 30, 2022 (unaudited) | |
| 23,000,000 | | |
$ | 238,303,465 | | |
| 5,750,000 | | |
$ | 575 | | |
$ | - | | |
$ | (11,613,685 | ) | |
$ | (11,613,110 | |
The accompanying notes are an integral part
of these unaudited condensed financial statements.
PATRIA
LATIN AMERICAN OPPORTUNITY ACQUISITION CORP
CONDENSED STATEMENTS OF CASH FLOWS
(Unaudited)
| |
FOR THE NINE
MONTHS ENDED
SEPTEMBER 30,
2023 | | |
FOR THE NINE
MONTHS ENDED
SEPTEMBER 30,
2022 | |
Cash Flows from Operating Activities | |
| | |
| |
Net income | |
$ | 7,453,331 | | |
$ | 5,080,880 | |
Adjustments to reconcile net income to net cash used in operating activities: | |
| | | |
| | |
Realized gain on investments held in Trust Account | |
| (7,601,882 | ) | |
| (1,403,465 | ) |
Transaction costs allocated to derivative warrant liabilities | |
| - | | |
| 314,508 | |
Change in fair value of derivative warrant liabilities | |
| (780,000 | ) | |
| (4,720,500 | ) |
Changes in operating assets and liabilities: | |
| | | |
| | |
Prepaid expenses | |
| 173,901 | | |
| (373,145 | ) |
Accounts payable | |
| 226,158 | | |
| - | |
Accrued expenses | |
| 6,130 | | |
| 44,281 | |
Net cash used in operating activities | |
| (522,362 | ) | |
| (1,057,441 | ) |
Cash Flows from Investing Activities | |
| | | |
| | |
Investment of cash into Trust Account | |
| - | | |
| (236,900,000 | ) |
Proceeds from redemption of marketable securities held in Trust account | |
| 65,163,747 | | |
| - | |
Purchase of U.S. government treasury obligations | |
| (672,783,585 | ) | |
| (475,200,000 | ) |
Trust Account Withdrawal - tax payment | |
| | | |
| - | |
Proceeds from redemption of U.S. government treasury obligations | |
| 671,583,585 | | |
| 475,200,000 | |
Purchase of U.S. government treasury obligations | |
| - | | |
| | |
Net cash provided by (used in) investing activities | |
| 63,963,747 | | |
| (236,900,000 | ) |
Cash Flows from Financing Activities | |
| | | |
| | |
Redemption of Class A ordinary shares subject to possible redemption | |
| (65,163,747 | ) | |
| - | |
Proceeds from note payable and advances from related party | |
| 1,200,000 | | |
| - | |
Repayment of note payable | |
| (3,144 | ) | |
| (437,507 | ) |
Repayment of amount due to related party | |
| - | | |
| (147,190 | ) |
Proceeds from sale of Class A ordinary shares, gross subject to possible redemption | |
| - | | |
| 230,000,000 | |
Proceeds from sale of Private Placement Warrants | |
| - | | |
| 14,500,000 | |
Offering costs paid | |
| - | | |
| (5,151,744 | ) |
Net cash used in (provided by) financing activities | |
| (63,966,891 | ) | |
| 238,763,559 | |
| |
| | | |
| | |
Net (decrease) increase in cash | |
| (525,506 | ) | |
| 806,118 | |
Cash - beginning of period | |
| 707,749 | | |
| 440 | |
Cash - end of period | |
$ | 182,243 | | |
$ | 806,558 | |
| |
| | | |
| | |
Supplemental disclosure of noncash investing and financing activities: | |
| | | |
| | |
Initial class A shares subject to possible redemption | |
$ | - | | |
$ | 212,383,343 | |
Accretion of Class A shares to redemption value | |
$ | 8,801,882 | | |
$ | 25,920,122 | |
Offering costs included in accrued expenses | |
$ | - | | |
$ | 211,141 | |
Offering costs paid through promissory note - related party | |
$ | - | | |
$ | 150,333 | |
Deferred underwriting fees payable | |
$ | - | | |
$ | 8,050,000 | |
The accompanying notes are an integral part
of these unaudited condensed financial statements.
PATRIA LATIN AMERICAN OPPORTUNITY ACQUISITION
CORP.
NOTES TO CONDENSED FINANCIAL STATEMENTS
Note 1 – Description of Organization, Business Operations,
Liquidity and Going Concern Considerations
Patria Latin American Opportunity Acquisition
Corp. (the “Company”) is a blank check company incorporated in Cayman Islands on February 25, 2021. The Company was formed
for the purpose of effecting a merger, capital stock exchange, asset acquisition, ordinary shares purchase, reorganization, or similar
business combination with one or more businesses (the “Business Combination”). The Company is an emerging growth company and,
as such, the Company is subject to all of the risks associated with emerging growth companies.
As of September 30, 2023, the Company had not
commenced any operations. All activities for the period from February 25, 2021 (inception), through September 30, 2023, relates to the
Company’s formation, and the initial public offering (“IPO”) described below, and post-IPO expenses. The Company will
not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company will generate non-operating
income in the form of realized and unrealized gains on investments from the proceeds derived from the IPO.
On March 14, 2022, the Company consummated its
IPO of 23,000,000 units (the “Units”), including the issuance of 3,000,000 Units as a result of the underwriter’s exercise
in full of its over-allotment option. Each Unit consists of one Class A ordinary share of the Company, par value $0.0001 per share (the
“Class A Ordinary Shares”), and one-half of one redeemable warrant of the Company (each whole warrant, a “Public Warrant”),
with each Public Warrant entitling the holder thereof to purchase one Class A Ordinary Share for $11.50 per share, subject to adjustment.
The Units were sold at a price of $10.00 per Unit, generating gross proceeds to the Company of $230,000,000.
The Company’s sponsor is Patria SPAC LLC,
a Cayman Islands exempted limited partnership (the “Sponsor”). Simultaneously with the closing of the IPO and pursuant to
the private placement warrants purchase agreement, the Company completed the private sale of 14,500,000 warrants (the “Private Placement
Warrants” and together with the Public Warrants, the “Warrants”) to the Sponsor at a purchase price of $1.00 per Private
Placement Warrant, generating gross proceeds to the Company of $14,500,000.
Transaction costs amounted to $13,779,665, including
$8,050,000 in deferred underwriting fees payable, $4,600,000 in underwriting fees paid and $1,129,665 in other offering costs, of which
$314,508 were expensed and $13,456,157 charged to temporary equity.
Following the closing of the IPO on March 14,
2022, an amount of $236,900,000 ($10.30 per Unit) of the proceeds from the IPO and the sale of the Private Placement Warrants, comprised
of $225,400,000 of the proceeds from the IPO (which is net of $4,600,000 of the underwriter’s fees) and $11,500,000 of the proceeds
of the sale of Private Placement Warrants, was placed in a U.S.-based trust account (the “Trust Account”) at J.P. Morgan Chase
Bank, N.A. maintained by Continental Stock Transfer & Trust Company, acting as trustee. The funds in the Trust Account were invested
only in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act 1940, as amended (the
“Investment Company Act”), having a maturity of 185 days or less or in money market funds meeting certain conditions under
Rule 2a-7 promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations. Except with respect
to earnings on the funds held in the Trust Account that may be released to the Company to pay its taxes, if any, the proceeds from the
IPO and the sale of the Private Placement Warrants held in the Trust Account will not be released from the Trust Account until the earliest
of: (i) the completion of the Initial Business Combination; (ii) the redemption of the Class A Ordinary Shares included in the Units (the
“Public Shares”) if the Company is unable to complete the Initial Business Combination by 15 months after the closing of our
IPO on March 14, 2022 (or up to 21 months if the Company extends the period of time to consummate the Initial Business Combination in
accordance with the terms described in the Company’s final prospectus); or (iii) the redemption of the Public Shares properly submitted
in connection with a shareholder vote to amend the Company’s amended and restated memorandum and articles of association to (A)
modify the substance or timing of the Company’s obligation to allow redemption in connection with the Initial Business Combination
or to redeem 100% of the Public Shares if the Company has not consummated the Initial Business Combination by 15 months after the closing
of our IPO on March 14, 2022 (or up to 21 months if the Company extends the period of time to consummate the Initial Business Combination
in accordance with the terms described in the Company’s final prospectus) or (B) with respect to any other material provisions relating
to shareholders’ rights or pre-Initial Business Combination activity. The proceeds deposited in the Trust Account could become subject
to the claims of the Company’s creditors, if any, which could have priority over the claims of the Company’s public shareholders.
The remaining proceeds outside the Trust Account may be used to pay for business, legal and accounting due diligence on prospective acquisitions
and continuing general and administrative expenses.
On June 12, 2023, the Company held an extraordinary
general meeting of the Company’s shareholders (the “Extraordinary General Meeting”). At the Extraordinary General Meeting,
the Company’s shareholders approved amendments to the Company’s Amended and Restated Memorandum and Articles of Association
to extend the date (the “Termination Date”) by which the Company has to consummate an initial business combination from June
14, 2023 (the “Original Termination Date”) to June 14, 2024 (the “Articles Extension Date”), in addition to other
proposals. Accordingly, the Company now has up to June 14, 2024 to consummate its initial business combination. In connection with the
Extraordinary General Meeting, shareholders holding an aggregate of 6,119,519 of the Company’s Class A ordinary shares exercised
their right to redeem their shares on June 14, 2023. Following such redemptions, 16,880,481 ordinary shares remained outstanding and
subject to redemption. The Trust Account has a remainder balance of $180 million following the withdrawal for Class A ordinary shares
redemption. The Company also deposited into the Trust Account an aggregate of $300,000 in order to effect the extension of the termination
date for an additional one-month period, from June 14, 2023 to July 14, 2023. The purpose of the extension is to provide time for the
Company to complete a business combination. The Company made additional deposits of $300,000 into the Trust account on July 12, 2023,
August 12, 2023, and September 13, 2023, in connection with extensions from
July 14, 2023 through October 14, 2023. The Company will continue to deposit $300,000 into the Trust Account each month until the earlier
of the completion of a Business Combination or liquidation date. On October 10, 2023, the Company made additional deposit of $300,000
representing extension payment through November 14, 2023. On November 13, 2023, the Company made additional deposit of $300,000 representing extension payment through
December 14, 2023.
Initial Business Combination
The Company’s management has broad discretion
with respect to the specific application of the net proceeds of the IPO, although substantially all of the net proceeds are intended to
be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business
Combination successfully. The Company must complete one or more initial Business Combinations having an aggregate fair market value of
at least 80% of the net assets held in the Trust Account (as defined below) (excluding the amount of deferred underwriting commission
held in Trust and taxes payable on the income earned on the Trust Account) at the time of the agreement to enter into the initial Business
Combination. However, the Company only intends to complete a Business Combination if the post-business combination company owns or acquires
50% or more of the issued and outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient
for it not to be required to register as an investment company under the Investment Company Act 1940, as amended (the “Investment
Company Act”). Upon the closing of the IPO, management has agreed that an amount equal to at least $10.30 per Unit sold in the IPO,
including the proceeds from the sale of the Private Placement Warrants, was held in a Trust Account located in the United States with
Continental Stock Transfer & Trust Company acting as trustee, and invested only in United States “government securities”
within the meaning of Section 2(a)(16) of the Investment Company Act having a maturity of 185 days or less or in money market funds meeting
certain conditions under Rule 2a-7 promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations,
as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust
Account as described below. The Company provides the holders (the “Public Shareholders”) of the Company’s issued and
outstanding Class A Ordinary Shares, par value $0.0001 per share, sold in the IPO (the “Public Shares”) with the opportunity
to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a shareholder
meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek
shareholder approval of a Business Combination or conduct a tender offer will be made by the Public Shares for a pro rata portion of the
amount then held in the Trust Account. The per-share amount to be distributed to Public Shareholders who redeem their Public Shares will
not be reduced by the deferred underwriting commissions the Company will pay to the underwriters. If the Company seeks shareholder approval,
the Company will proceed with a Business Combination if a majority of the shares voted are voted in favor of the Business Combination.
If a shareholder vote is not required by law and the Company does not decide to hold a shareholder vote for business or other legal reasons,
the Company will, pursuant to its Amended and Restated Articles of Association (the “Articles of Association”), conduct the
redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and file tender offer
documents with the SEC prior to completing a Business Combination. If, however, shareholder approval of the transaction is required by
law, or the Company decides to obtain shareholder approval for business or legal reasons, the Company will offer to redeem the Public
Shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. Additionally,
each Public Shareholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction.
If the Company seeks shareholder approval in connection with a Business Combination, the initial shareholders (as defined below) have
agreed to vote their Founder Shares (as defined below) and any Public Shares purchased during or after the IPO in favor of a Business
Combination. In addition, the initial shareholders have agreed to waive their redemption rights with respect to their Founder Shares and
Public Shares in connection with the completion of a Business Combination.
The Articles of Association provides that a Public
Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as
a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)),
will be restricted from redeeming its shares with respect to more than an aggregate of 15% of the Public Shares, without the prior consent
of the Company. The holders of the Founder Shares (the “initial shareholders”) have agreed not to propose an amendment to
the Articles of Association (A) to modify the substance or timing of the Company’s obligation to allow redemption in connection
with a Business Combination or to redeem 100% of the Public Shares if the Company does not complete a Business Combination within the
Combination Period (as defined below) or (B) with respect to any other provision relating to shareholders’ rights or pre-initial
Business Combination activity, unless the Company provides the Public Shareholders with the opportunity to redeem their Public Shares
in conjunction with any such amendment.
If the Company is unable to complete a Business
Combination by 27 months after the closing of our IPO on March 14, 2022 of the IPO (the “Combination Period”) and the Company’s
shareholders have not amended the Articles of Association to extend such Combination Period, the Company will (i) cease all operations
except for the purpose of winding up; (ii) as promptly as reasonably possible but no more than ten business days thereafter subject to
lawfully available funds therefor, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then
on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to the Company
to pay its taxes, if any (less up to $100,000 of interest to pay dissolution expenses) divided by the number of the then outstanding Public
Shares, which redemption will completely extinguish Public Shareholders’ rights as shareholders (including the right to receive
further liquidation distributions, if any), subject to applicable law; and (iii) as promptly as reasonably possible following such redemption,
subject to the approval of the remaining shareholders and the board of directors, liquidate and dissolve, subject in each case to the
Company’s obligations under Cayman law to provide for claims of creditors and the requirements of other applicable law.
The initial shareholders have agreed to waive
their rights to liquidating distributions from the Trust Account with respect to the Founder Shares if the Company fails to complete a
Business Combination within the Combination Period. However, if the initial shareholders acquire Public Shares after the IPO, they will
be entitled to liquidating distributions from the Trust if the Company fails to complete a Business Combination within the Combination
Period. The underwriters have agreed to waive their rights to the deferred underwriting commission held in the Trust Account in the event
the Company does not complete a Business Combination within in the Combination Period and, in such event, such amounts will be included
with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such
distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account
assets) will be only $10.30. In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company
if and to the extent any claims by a third party (except for the Company’s independent registered public accounting firm) for services
rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction
agreement (a “Target”), reduce the amount of funds in the Trust Account to below (i) $10.30 per unit or (ii) the lesser amount
per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of the
trust assets, in each case net of interest which may be withdrawn to pay taxes, provided that such liability will not apply to any claims
by a third party or Target that executed a waiver of any and all rights to seek access to the Trust Account nor will it apply to any claims
under the Company’s indemnity of the underwriters of the IPO against certain liabilities, including liabilities under the Securities
Act of 1933, as amended (the “Securities Act”). In the event that an executed waiver is deemed to be unenforceable against
a third party, our sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to
reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all
vendors, service providers (other than the Company’s independent registered public accounting firm), prospective target businesses
or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim
of any kind in or to monies held in the Trust Account.
Liquidity and Going Concern Consideration
As of September 30, 2023, the Company had working
capital of $173,155,304. Of the net proceeds from the IPO and associated sale of Private Placement Warrants, $236,900,000 of cash was
placed in the Trust Account. The working capital surplus includes the amount of restricted marketable securities held in the Trust Account,
deferred underwriting fees payable and derivative warrant liabilities, all of which have been classified as current at September 30, 2023
as a result of the Company being less than 12 months away from consuming the assets held in the Trust Account to either consummate a business
combination or to liquidate. Working capital would be $(1,184,817) if the line items described above were not included in the working
capital calculation. Cash of $182,243 was held outside of the Trust Account and is available for the Company’s working capital purposes
as of September 30, 2023.
The Company anticipates that the cash held outside
of the Trust Account as of September 30, 2023 will not be sufficient to allow the Company to operate for at least the next 12 months from
the issuance of this unaudited condensed financial statements, assuming that a Business Combination is not consummated during that time.
Over this time period, the Company will be using the funds held outside of the Trust Account for paying existing accounts payable and
accrued liabilities, identifying and evaluating prospective initial Business Combination candidates, performing due diligence on prospective
target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating
and consummating the Business Combination. These conditions raise substantial doubt about the Company’s ability to continue as a
going concern for a period of time within one year after the date that the unaudited condensed financial statements are issued. Management
plans to address this uncertainty through the Business Combination as discussed above. In addition, the Sponsor or an affiliate of the
Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required
under the Working Capital Loans. There is no assurance that the Company’s plans to consummate the Business Combination will be successful
or successful within the Combination Period or that the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers
and directors will loan the Company funds as may be required under the Working Capital Loans.
These unaudited condensed financial statements
do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be
necessary should the Company be unable to continue as a going concern.
Risks and Uncertainties
Global economic conditions have been worsening,
with disruptions to, and volatility in, the credit and financial markets and rising inflation and interest rates in the U.S. If these
conditions persist and deepen, the Company could experience an inability to access additional capital, or our liquidity could otherwise
be impacted. Management continues to evaluate the impact related to rising interest rates and current market condition and has concluded
while it is reasonably possible that these factors could have a negative effect on the Company’s financial position and results
of its operations, the specific impact is not readily determinable as of the date of the unaudited condensed financial statements. The
financial statements do not include any adjustments that might result from the outcome of this uncertainty.
The credit and financial markets have experienced
extreme volatility and disruptions due to the current conflict between Ukraine and Russia. The conflict is expected to have further global
economic consequences, including but not limited to the possibility of severely diminished liquidity and credit availability, declines
in consumer confidence, declines in economic growth, increases in inflation rates and uncertainty about economic and political stability.
In addition, the United States and other countries have imposed sanctions on Russia, which increases the risk that Russia, as a retaliatory
action, may launch cyberattacks against the United States, its government, infrastructure and businesses. Any of the foregoing consequences,
including those we cannot yet predict, may cause our business, financial condition, results of operations and the price of our ordinary
shares to be adversely affected.
Note 2 – Summary of Significant Accounting Policies
Basis of Presentation
The accompanying unaudited condensed financial
statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S.
GAAP”) for information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the Securities and
Exchange Commission (the “SEC”). Certain information or footnote disclosures normally included in financial statements prepared
in accordance with U.S. GAAP have been or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly,
they do not include all the information and footnotes necessary for a comprehensive presentation of financial position, results of operations,
or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting
of a normal recurring nature, which are necessary for a fair statement of the financial position, operating results and cash flows for
the periods presented.
Emerging Growth Company
The Company is an “emerging growth company,”
as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”),
and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that
are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting
firm attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation
in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive
compensation and shareholder approval of any golden parachute payments not previously approved.
Further, Section 102(b)(1) of the JOBS Act exempts
emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that
is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered
under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging
growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth
companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period,
which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company,
as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard.
This may make comparison of the Company’s financial statements with another public company that is neither an emerging growth company
nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential
differences in accounting standards used.
Use of Estimates
The preparation of this unaudited condensed financial
statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported
amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial
statements and the reported amounts of expenses during the reporting period.
Making estimates requires management to exercise
significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances
that existed at the date of the unaudited condensed financial statements, which management considered in formulating its estimate, could
change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those
estimates.
Cash
and Cash Equivalents
The Company considers all short-term investments
with an original maturity of three months or less when purchased to be cash equivalents. The Company had $182,243 and $707,749 in cash
outside of the funds held in the Trust Account, as of September 30, 2023 and December 31, 2022, respectively. The Company did not have
any cash equivalents as of September 30, 2023 and December 31, 2022.
Investments Held in Trust Account
The assets held in the Trust Account were held
in U.S. government treasury obligations with maturities of 185 days or less, which were invested in U.S. Treasury securities. Trading
securities are presented on the balance sheet at fair value at the end of each reporting period. Earnings on these securities is included
in realized gain on investments held in Trust Account in the accompanying unaudited condensed statements of operations.
Financial Instruments
The fair value of the Company’s assets and
liabilities, which qualify as financial instruments under Accounting Standards Codification (“ASC”) 820, “Fair Value
Measurement,” approximates the carrying amounts represented in the balance sheet. The Company’s derivative financial instruments
are accounted for as liabilities, and the derivative instrument is recorded at its fair value on the issuance date and is then re-valued
at each reporting date. The fair value of the Company’s derivative financial instruments is evaluated at the end of each reporting
period, with changes in the fair value reported in the unaudited condensed statements of operations. The Company had no other financial
assets or liabilities that were required to be measured at fair value on a recurring basis.
Fair Value Measurements
Fair value is defined as the price that would
be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement
date. U.S. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy
gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and
the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:
Level 1 – Valuations based on unadjusted
quoted prices in active markets for identical assets or liabilities that the Company has the ability to access. Valuation adjustments
and block discounts are not applied. Since valuations are based on quoted prices that are readily and regularly available in an active
market, valuation of these securities does not entail a significant degree of judgment.
Level 2 – Valuations based on (i) quoted
prices in active markets for similar assets and liabilities, (ii) quoted prices in markets that are not active for identical or similar
assets, (iii) inputs other than quoted prices for the assets of liabilities, that are observable, or (iv) inputs that are derived
principally from or corroborated by market data through correlation or other means.
Level 3 – Valuations based on inputs that
are unobservable and significant to the overall fair value measurement.
Net Income (Loss) per Ordinary Share
The Company complies with accounting and disclosure
requirements of ASC 260, “Earnings Per Share.” Net income (loss) per ordinary share is computed by dividing net income (loss)
by the weighted average number of ordinary share outstanding during the period. The Company did not have any dilutive securities and other
contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. For the
three and nine months ended September 30, 2023, the Company has not considered the effect of the warrants sold in the Initial Public Offering
and Private Placements to purchase Class A Ordinary Shares in the calculation of diluted income (loss) per share, since their inclusion
is contingent on a future event. For the three and nine months ended September 30, 2022 their inclusion would be anti-dilutive under the
treasury stock method. As a result, diluted income (loss) per share is the same as basic income (loss) per share for the periods presented.
A
reconciliation of the income (loss) per share is below:
| |
For The Three Months
Ended September 30, 2023 | | |
For The Three Months
Ended September 30, 2022 | |
Net income (loss) | |
$ | 1,766,214 | | |
$ | (438,683 | ) |
Accretion of temporary equity in excess of fair value | |
| (3,260,877 | ) | |
| (1,101,855 | ) |
Net income (loss) including accretion of temporary equity in excess of fair value | |
$ | (1,494,663 | ) | |
$ | (1,540,538 | ) |
| |
For The Nine Months
Ended September 30, 2023 | | |
For The Nine Months
Ended September 30, 2022 | |
Net income (loss) | |
$ | 7,453,331 | | |
$ | 5,080,880 | |
Accretion of temporary equity in excess of fair value | |
| (8,801,882 | ) | |
| (25,920,122 | ) |
Net income (loss) including accretion of temporary equity in excess of fair value | |
$ | (1,348,551 | ) | |
$ | (20,839,242 | ) |
The Company’s unaudited condensed statements
of operations include a presentation of income (loss) per share for shares of ordinary shares subject to possible redemption in a manner
similar to the two-class method of earnings per share. With respect to the accretion of the Class A Ordinary Shares subject to possible
redemption and consistent with ASC 480, “Distinguishing Liabilities from Equity,” in accordance with ASC 480-10-S99-3A, the
Company has treated the accretion in excess of fair value in the same manner as a dividend, to the extent the redemption value exceeds
the fair value, in the calculation of the net income (loss) per ordinary share.
| |
For The Three Months Ended September 30, 2023 | | |
For The Three Months Ended September 30, 2022 | |
| |
Class A - Temporary Equity | | |
Class B | | |
Class A - Temporary Equity | | |
Class B | |
Basic and diluted net income (loss) per share | |
| | |
| | |
| | |
| |
Numerator | |
| | |
| | |
| | |
| |
Allocation of net income (loss) including accretion of temporary equity in excess of fair value | |
$ | (1,114,896 | ) | |
$ | (379,767 | ) | |
$ | (1,232,430 | ) | |
$ | (308,108 | ) |
Deemed dividend for accretion of temporary equity in excess of fair value | |
| 3,260,877 | | |
| - | | |
| 1,101,855 | | |
| - | |
Allocation of net income and deemed dividend | |
$ | 2,145,981 | | |
$ | (379,767 | ) | |
$ | (130,575 | ) | |
$ | (308,108 | ) |
Denominator | |
| | | |
| | | |
| | | |
| | |
Weighted average shares outstanding, basic and diluted | |
| 16,880,481 | | |
| 5,750,000 | | |
| 23,000,000 | | |
| 5,750,000 | |
| |
| | | |
| | | |
| | | |
| | |
Basic and diluted net income (loss) per share | |
$ | 0.13 | | |
$ | (0.07 | ) | |
$ | (0.01 | ) | |
$ | (0.05 | ) |
| |
For The Nine Months Ended September 30, 2023 | | |
For The Nine Months Ended September 30, 2022 | |
| |
Class A - Temporary Equity | | |
Class B | | |
Class A - Temporary Equity | | |
Class B | |
Basic and diluted net income (loss) per share | |
| | |
| | |
| | |
| |
Numerator | |
| | |
| | |
| | |
| |
Allocation of net income (loss) including accretion of temporary equity in excess of fair value | |
$ | (1,053,287 | ) | |
$ | (295,264 | ) | |
$ | (14,953,478 | ) | |
$ | (5,885,764 | ) |
Deemed dividend for accretion of temporary equity in excess of fair value | |
| 8,801,882 | | |
| - | | |
| 25,920,122 | | |
| - | |
Allocation of net income and deemed dividend | |
$ | 7,748,595 | | |
$ | (295,264 | ) | |
$ | 10,966,644 | | |
$ | (5,885,764 | ) |
Denominator | |
| | | |
| | | |
| | | |
| | |
Weighted average shares outstanding, basic and diluted | |
| 20,511,844 | | |
| 5,750,000 | | |
| 16,934,066 | | |
| 5,552,198 | |
| |
| | | |
| | | |
| | | |
| | |
Basic and diluted net income (loss) per share | |
$ | 0.38 | | |
$ | (0.05 | ) | |
$ | 0.65 | | |
$ | (1.06 | ) |
Class A Ordinary Shares Subject to Possible Redemption
The Company accounts for its Class A Ordinary
Shares subject to possible redemption in accordance with the guidance in ASC 480.
Conditionally redeemable ordinary shares (including
ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence
of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares
are classified as shareholders’ equity. The Company’s Class A Ordinary Shares feature contains certain redemption rights
that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly,
Class A Ordinary Shares subject to possible redemption are classified as temporary equity, outside of the shareholders’ equity
section of the Company’s balance sheets. Accordingly, as of September 30, 2023, 16,880,481 shares of Class A Ordinary Shares
subject to possible redemption is presented at redemption value as temporary equity, outside of the shareholders’ deficit section
of the Company’s balance sheets.
The Class A Ordinary Shares subject to possible
redemption are subject to the subsequent measurement guidance in ASC 480-10-S99. Under such guidance, the Company must subsequently measure
the shares to their redemption amount because, as a result of the allocation of net proceeds to transaction costs, the initial carrying
amount of the ordinary shares is less than $10.00 per share. In accordance with the guidance, the Company has elected to measure the ordinary
shares subject to possible redemption to their redemption amount (i.e., $10.30 per share) immediately as if the end of the first reporting
period after the IPO, March 14, 2022, was the redemption date. Such changes are reflected in additional paid-in capital, or in the absence
of additional paid-in capital, in accumulated deficit. For the year ended December 31, 2022, the Company recorded an accretion of $27,928,643
of which $9,275,425 was recorded in additional paid-in capital and $18,653,218 was recorded in accumulated deficit.
At September 30, 2023, 16,880,481 ordinary shares
subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ deficit section
of the Company’s balance sheets.
Gross proceeds | |
$ | 230,000,000 | |
Less: | |
| | |
Class A ordinary shares issuance costs | |
| (13,465,157 | ) |
Fair value of Public Warrants at issuance | |
| (4,151,500 | ) |
Plus: | |
| | |
Accretion of carrying value to redemption value | |
| 27,928,643 | |
Class A ordinary shares subject to possible redemption at December 31, 2022 | |
$ | 240,311,986 | |
Remeasurement of carrying value to redemption value | |
| 8,801,882 | |
Redemption of Class A ordinary shares | |
| (65,163,747 | ) |
Class A ordinary shares subject to possible redemption at September 30, 2023 | |
$ | 183,950,121 | |
Derivative Financial Instruments
The Company evaluates its financial instruments
to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC 815,
“Derivatives and Hedging.” For derivative financial instruments that are accounted for as liabilities, the derivative instrument
is initially recorded at its fair value on the issuance date and is then re-valued at each reporting date, with changes in the fair value
reported in the unaudited condensed statements of operations. The classification of derivative instruments, including whether such instruments
should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified
in the balance sheet as current or non-current based on whether or not net- cash settlement or conversion of the instrument could be required
within 12 months of the balance sheet date.
Derivative Warrant Liabilities
The Company accounts for warrants as either equity-classified
or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance
in ASC 480 and ASC 815. The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet
the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under
ASC 815, including whether the warrants are indexed to the Company’s own ordinary shares, among other conditions for equity classification.
This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent
quarterly period end date while the warrants are outstanding.
For issued or modified warrants that meet all
of the criteria for equity classification, the warrants are required to be recorded as a component of additional paid-in capital at the
time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required
to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair
value of the warrants are recognized as a non-cash gain or loss under the caption change in fair value of derivative warrant liabilities
on the unaudited condensed statements of operations. The warrants were valued using a Monte Carlo simulation model until the Class A ordinary
shares and warrants began trading separately on May 4, 2022. Since May 4, 2022, the Public Warrants have been measured using the listed
market price and the Private Placement Warrants have been measured by reference to the trading price of the Public Warrants.
The Class A Ordinary Shares and warrants comprising
the units began separate trading on the 52nd day following the date of the IPO. No fractional warrants issued upon separation of the units
and only whole warrants will trade. Accordingly, unless a multiple of two units is purchased, the number of warrants issuable to you upon
separation of the units will be rounded down to the nearest whole number of warrants.
Additionally, the units will automatically separate
into their component parts and will not be traded after completion of the Initial Business Combination.
Share-based Compensation
The Company accounts for Founder Shares issued
to its independent directors in accordance with SEC Staff Accounting Bulletin 5T and ASC 718, “Compensation-Stock Compensation.”
The fair value of the Founder Shares issued in this arrangement was determined using the implied stock price as of the date of Initial
Public Offering of the Company’s Class A ordinary shares and the probability of the success of the Business Combination.
Offering Costs
Offering costs consist of legal, accounting, underwriting
and other costs incurred through the balance sheet date that are directly related to the IPO. Upon the completion of the IPO, the offering
costs were allocated using the relative fair values of the Company’s Class A Ordinary Shares and its Public Warrants and Private
Placement Warrants. The costs allocated to warrants were recognized in other expenses and those related to the Company’s Class A
Ordinary Shares were charged against the carrying value of Class A Ordinary Shares. The Company complies with the requirements of the
ASC 340-10-S99-1, “Other Assets and Deferred Costs.”
Income Taxes
The Company follows the asset and liability method
of accounting for income taxes under ASC 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated
future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities
and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable
income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and
liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are
established, when necessary, to reduce deferred tax assets to the amount expected to be realized.
ASC 740 prescribes a recognition threshold and
a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax
return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities.
The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes
accrued interest and penalties related to unrecognized tax benefits as income tax expense. As of September 30, 2023 and 2022, there were
no unrecognized tax benefits and no amounts were accrued for the payment of interest and penalties.
There is currently no taxation imposed on income
by the Government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company.
U.S. taxation could be imposed if the Company is engaged in a U.S. trade or business. The Company is not expected to be treated as engaged
in a U.S. trade or business at this time. Additionally, given the nature of the investment income generated from the funds held in the
trust account, it is not subject to tax withholdings in the U.S. Moreover, the Company determined that no income tax liability would arise
from any other jurisdictions outside of the Cayman Islands. Consequently, income taxes are not reflected in the Company’s unaudited
condensed financial statements.
Concentration of Credit Risk
Financial instruments that potentially subject
the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal
Depository Insurance Coverage. The Company has not experienced losses on this account and management believes the Company is not exposed
to significant risks on such account.
Recent Accounting Pronouncements
In August 2020, the Financial Accounting Standards
Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2020-06, Debt—Debt with Conversion and Other
Options (Subtopic 470-20) and Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts
in an Entity’s Own Equity (“ASU 2020- 06”), which simplifies accounting for convertible instruments by removing major
separation models required under current U.S. GAAP. As a result of ASU 2020 – 06, more convertible debt instruments will be accounted
for as a single liability measured at its amortized cost and more convertible preference shares will be accounted for as a single equity
instrument measured at its historical cost, as long as no features require bifurcation and recognition as derivatives. The amendments
are effective for smaller reporting companies for fiscal years beginning after December 15, 2023, including interim periods within those
fiscal years. The Company is evaluating the impact of ASU 2020-06 on its financial statements.
The Company’s management does not believe
that any other recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on
the accompanying unaudited condensed financial statements.
Note 3 – Initial Public Offering
Pursuant to the IPO, the Company sold 23,000,000
Units, at a purchase price of $10.00 per Unit. Each Unit consists of one share of Class A Ordinary Share and one-half of one redeemable
warrant (“Public Warrant”). Each Public Warrant entitles the holder to purchase one share of Class A Ordinary Shares at an
exercise price of $11.50 per whole share.
The Company had granted the Underwriters in the
IPO (the “Underwriters”) a 45-day option to purchase up to 3,000,000 additional Units to cover over-allotments, which was
exercised in full on the IPO date.
On June 12, 2023, 6,119,519 Class A ordinary shares
were redeemed by the Company’s shareholders in connection with the Extraordinary General Meeting mentioned in Note 1. Following
such redemptions, 22,630,481 ordinary shares remained outstanding, consisting of 16,880,481 Class A ordinary shares and 5,750,000 Class
B ordinary shares.
Note 4 – Private Placement Warrants
Simultaneously with the closing of the IPO, the
Sponsor purchased an aggregate of 14,500,000 of Private Placement Warrants, including the overallotment option, at a price of $1.00 per
Private Placement Warrant ($14,500,000 in the aggregate). Each Private Placement Warrant is exercisable to purchase one share of Class
A Ordinary Shares at a price of $11.50 per share. The proceeds from the sale of the Private Placement Warrants were added to the net proceeds
from the IPO held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds
from the sale of the Private Placement Warrants will be used to fund the redemption of the Public Shares (subject to the requirements
of applicable law) and the Private Placement Warrants will expire worthless. Upon the purchase of the Private Placement Warrants by the
Sponsor, the Company recorded the excess proceeds received over the fair value of the Private Placement Warrants as additional paid-in
capital amounting to $9,251,000.
Note 5 – Related Party Transactions
Founder Shares
On
March 3, 2021, one of our officers paid $25,000, to cover certain of our offering costs, in exchange for an aggregate of 7,187,500 Class
B ordinary shares (the “Founder Shares”), which were temporarily issued to such officer until such shares were transferred
to our sponsor in April 2021. Our Sponsor was formed on March 9, 2021. In February 2022, our Sponsor forfeited 1,437,500 Founder Shares
for no consideration, remaining with 5,750,000 Founder Shares. Prior to the IPO, on March 9, 2022, our Sponsor transferred 30,000 of
our Founder Shares to each of our three independent directors. These 90,000 shares were not subject to forfeiture. The allocation of
the Founder Shares to the directors is in the scope of ASC 718. Under ASC 718, share-based compensation associated with equity-classified
awards is measured at fair value upon the grant date. The Company used the Monte Carlo model to estimate the fair value associated with
the Founder Shares granted. The fair value of the 90,000 shares granted to the Company’s directors in March 2022 was $662,245 or
$7.36 per share. The Founder Shares were granted subject to a performance condition, the occurrence of an Initial Business Combination.
Compensation expense related to the Founder Shares is recognized only when the performance condition is probable of occurrence under
ASC 718. The Company determined the performance conditions are not considered probable, and, therefore, no share-based compensation expense
was recognized for period ended September 30, 2023 and 2022. As of September 30, 2023 and 2022, the unrecognized stock compensation expense
was $662,245.
On March 14, 2022, the underwriters fully exercised
the over-allotment option; thus, the 750,000 Founder Shares are no longer subject to forfeiture.
The Sponsor has agreed not to transfer, assign
or sell any of their founder shares and any Class A Ordinary Shares issued upon conversion thereof until the earlier to occur of (A) one
year after the completion of our initial business combination; or (B) subsequent to our initial business combination, (x) if the last
reported sale price of the Class A Ordinary Shares equals or exceeds $12.00 per share (as adjusted for share sub-divisions, share capitalizations,
reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days
after our initial business combination, or (y) the date following the completion of our initial business combination on which we complete
a liquidation, merger, amalgamation, stock exchange, reorganization or other similar transaction that results in all of our public shareholders
having the right to exchange their Class A Ordinary Shares for cash, securities or other property.
The Founder Shares will automatically convert
into Class A Ordinary Shares concurrently with or immediately following the consummation of the Company’s Initial Business
Combination on a one-for-one basis, subject to adjustment for share sub-divisions, share capitalizations, reorganizations, recapitalizations
and the like, and subject to further adjustment as provided herein. In the case that additional Class A Ordinary Shares or equity-linked
securities are issued or deemed issued in connection with the Company’s Initial Business Combination, the number of Class A
Ordinary Shares issuable upon conversion of all Founder Shares will equal, in the aggregate, 20% of the total number of Class A Ordinary
Shares outstanding after such conversion (after giving effect to any redemptions of Class A Ordinary Shares by Public Shareholders),
including the total number of Class A Ordinary Shares issued, or deemed issued or issuable upon conversion or exercise of any equity-linked
securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of the Initial Business
Combination, excluding any Class A Ordinary Shares or equity-linked securities exercisable for or convertible into Class A Ordinary
Shares issued, or to be issued, to any seller in the Initial Business Combination and any Private Placement Warrants issued to the Sponsor,
or the Company’s officers or directors upon conversion of Working Capital Loans; provided that such conversion of Founder Shares
will never occur on a less than one-for-one basis.
Promissory Note – Related Party
On March 3, 2021, the Company issued an unsecured
promissory note (the “Promissory Note”) to the Sponsor, pursuant to which the Company may borrow up to an aggregate principal
amount of $250,000. The Promissory Note is non-interest bearing and payable on the earlier of (i) March 31, 2023, and (ii) the completion
of the IPO. On January 31, 2022, the Company amended the unsecured Promissory Note to provide an additional borrowing of $250,000, for
a total borrowing capacity of $500,000. Promissory note balance as of December 31, 2021 was $437,508 which was fully paid upon the Company’s
consummation of its initial public offering. There is no outstanding balance on the promissory note as of March 31, 2023 and December
31, 2022, respectively.
Due to Related Party
As
of September 30, 2023 and December 31, 2022, the Company had an outstanding balance of $1,2000,000 and $3,144 due to the Sponsor related
to expenses paid by the Sponsor on behalf of the Company. This amount is due on demand. During the year ended December 31, 2022, the
Company borrowed $150,334 from the Sponsor, all of which was repaid except the outstanding balance of $3,144. As of September 30, 2023,
the Company has deposited an aggregate of $1,200,000 into the Trust Account in the form of a loan in connection with the extension of
the termination date for an additional four-month period, from June 14, 2023 to October 14, 2023. The loan has no interest and is forgiven should the Company not complete
an initial business combination. The Sponsor is committed to extending the $300,000 monthly loan to the Company till the earlier of liquidation
date or the consummation of an initial business combination. On October 10, 2023, the Company borrowed additional $300,000 from its Sponsor
and deposited such into the Trust Account as extension deposit through November 14, 2023. On November 13, 2023, the Company made additional deposit of $300,000
representing extension payment through December 14, 2023.
Administrative Services Agreement
Following
our IPO, the Company pays the Sponsor or an affiliate a monthly fee of $10,000 for office space, utilities, secretarial and administrative
services. In August 2023, the Company and its Sponsor executed an agreement to discontinue the remittance of administrative fees to the
Sponsor with an effective date of August 1, 2023. For the three and nine months ended September 30, 2023, the Company incurred and paid
$0 and $60,000 in administrative support fees, respectively. For the three and nine months ended September 30, 2022, the Company incurred
and paid $30,000 and $65,484 in administrative support fees,
respectively.
Working Capital Loans
In order to finance transaction costs in connection
with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may,
but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a
Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company.
Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination
does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds
held in the Trust Account would be used to repay the Working Capital Loans. The Working Capital Loans would either be repaid upon consummation
of a Business Combination or, at the lender’s discretion, up to $2,000,000 of such Working Capital Loans may be convertible into
warrants of the post Business Combination entity at a price of $1.00 per warrant. The warrants would be identical to the Private Placement
Warrants. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements
exist with respect to such loans. As of September 30, 2023 and December 31, 2022, the Company had no borrowings under the Working Capital
Loans.
Note 6 – Commitments and Contingencies
Registration Rights
The holders of Founder Shares and Private Placement
Warrants, including any that may be issued upon conversion of Working Capital Loans, if any (and any Class A Ordinary Shares issuable
upon the exercise of the Private Placement Warrants, including any that may be issued upon conversion of the Working Capital Loans), will
be entitled to registration rights pursuant to a registration rights agreement entered into prior to the consummation of the IPO. These
holders will be entitled to certain demand and “piggyback” registration rights. However, the registration rights agreement
provides that the Company is not required to effect or permit any registration or cause any registration statement to become effective
until termination of the applicable lock-up period. The Company will bear the expenses incurred in connection with the filing of any such
registration statements.
Underwriting Agreement
The Company granted the underwriter a 45-day option
from the date of the IPO to purchase up to an additional 3,000,000 Units to cover over-allotments. The underwriter fully exercised its
over-allotment option concurrently with the close of the IPO. The underwriter was entitled to a cash underwriting discount of $0.20 per
Unit (or $4,600,000) of the gross proceeds of the IPO. Additionally, the underwriter is entitled to a deferred underwriting commission
of $0.35 per Unit (or $8,050,000) of the gross proceeds of the IPO upon the completion of the Company’s Initial Business Combination.
The deferred underwriting commissions will become payable to the underwriter from the amounts held in the Trust Account solely in the
event that the Company completes an Initial Business Combination, subject to the terms of the underwriting agreement.
Note 7 – Derivative Warrant Liabilities
The Company accounted for the 26,000,000 Warrants
issued in connection with the IPO (the 11,500,000 of Public Warrants and the 14,500,000 of Private Placement Warrants) in accordance with
the guidance contained in ASC 815-40. Such guidance provides that because the Warrants do not meet the criteria for equity treatment thereunder,
each Warrant much be recorded as a liability. Accordingly, the Company classifies each Warrant as a liability at its fair value. This
liability is subject to re-measurement at each balance sheet date. With each such re-measurement, the warrant liability will be adjusted
to fair value, with the change in fair value recognized in the Company’s unaudited condensed statements of operations.
Each whole Warrant entitles the holder thereof
to purchase one Class A Ordinary Share at a price of $11.50 per share, subject to adjustment. Only whole Warrants are exercisable. The
Warrants will become exercisable 30 days after the completion of the Initial Business Combination and will expire five years after the
completion of the Initial Business Combination or earlier upon redemption or liquidation.
Public Warrants may only be exercised for a
whole number of shares. No fractional Public Warrants issued upon separation of the Units and only whole Public Warrants will trade.
The Public Warrants will become exercisable 30 days after the completion of an Initial Business Combination provided that the
Company has an effective registration statement under the Securities Act covering the Class A Ordinary Shares issuable upon
exercise of the Public Warrants and a current prospectus relating to them is available and such shares are registered, qualified or
exempt from registration under the securities, or blue sky, laws of the state of residence of the holder (or holders are permitted
to exercise their Public Warrants on a cashless basis under certain circumstances as a result of (i) the Company’s
failure to have an effective registration statement by the 60th business day after the closing of the Initial Business
Combination or (ii) a notice of redemption described under “Redemption of Warrants when the price per Class A
Ordinary Share equals or exceeds $10.00”). The Company has agreed that as soon as practicable, but in no event later than
20 business days after the closing of its Initial Business Combination, the Company will use its commercially reasonable efforts to
file with the SEC a post-effective amendment to the registration statement for the IPO or a new registration statement covering the
Class A Ordinary Shares issuable upon exercise of the Warrants and will use its commercially reasonable efforts to cause the
same to become effective within 60 business days after the closing of the Company’s Initial Business Combination and to
maintain a current prospectus relating to those Class A Ordinary Shares until the Warrants expire or are redeemed. If the
shares issuable upon exercise of the Public Warrants are not registered under the Securities Act in accordance with the above
requirements, the Company will be required to permit holders to exercise their Public Warrants on a cashless basis. However, no
Warrant will be exercisable for cash or on a cashless basis, and the Company will not be obligated to issue any shares to holders
seeking to exercise their Warrants, unless the issuance of the shares upon such exercise is registered or qualified under the
securities laws of the state of the exercising holder, or an exemption from registration is available. Notwithstanding the above, if
the Company’s Class A Ordinary Shares are at the time of any exercise of a Public Warrant not listed on a national
securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the
Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their Public Warrants to do so on a
“cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects,
it will not be required to file or maintain in effect a registration statement, and in the event the Company does not so elect, it
will use its commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an
exemption is not available.
The Warrants have an exercise price of $11.50
per share, subject to adjustments, and will expire five years after the completion of an Initial Business Combination or earlier upon
redemption or liquidation. In addition, if (x) the Company issues additional Class A Ordinary Shares or equity-linked securities
for capital raising purposes in connection with the closing of the Initial Business Combination at an issue price or effective issue price
of less than $9.20 per Class A Ordinary Share (with such issue price or effective issue price to be determined in good faith by the
board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares
held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate
gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding
of the Initial Business Combination on the date of the consummation of the Initial Business Combination (net of redemptions) and (z) the
volume weighted average trading price of Class A Ordinary Shares during the 20 trading day period starting on the trading day prior
to the day on which the Company consummates the Initial Business Combination (such price, the “Market Value”) is below $9.20
per share, the exercise price of the Warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value
and the Newly Issued Price, and the $10.00 and $18.00 per share redemption trigger prices described under “Redemption of Warrants
when the price per Class A Ordinary Share equals or exceeds $10.00” and “Redemption of Warrants when the price per
Class A Ordinary Share equals or exceeds $18.00” will be adjusted (to the nearest cent) to be equal to 100% and 180% of the
higher of the Market Value and the Newly Issued Price, respectively.
The Private Placement Warrants are identical to
the Public Warrants, except that, so long as they are held by the Sponsor or its permitted transferees, (i) they will not be redeemable
by the Company, (ii) they (including the Class A Ordinary Shares issuable upon exercise of these Warrants) may not, subject
to certain limited exceptions, be transferred, assigned or sold by the Sponsor until 30 days after the completion of the Initial
Business Combination, (iii) they may be exercised by the holders on a cashless basis, (iv) are subject to registration rights
and (v) use a different Black-Scholes Warrant Model for purposes of calculating the Black-Scholes Warrant Value (as defined in the warrant
agreement).
On the exercise of any Warrant, the Warrant exercise
price will be paid directly to us and not placed in the Trust Account.
Redemption of Warrants when the price per Class
A Ordinary Share equals or exceeds $18.00: Once the Warrants become exercisable, the Company may redeem the outstanding Warrants (except
as described herein with respect to the Private Placement Warrants):
|
● |
in whole and not in part; |
|
● |
at a price of $0.01 per Warrant; |
|
● |
upon a minimum of 30 days’ prior written notice of redemption; and |
|
● |
if, and only if, the last reported sale price of Class A Ordinary Shares equals or exceeds $18.00 per share (as adjusted) for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders. |
The Company will not redeem the Warrants as described
above unless an effective registration statement under the Securities Act covering the Class A Ordinary Shares issuable upon exercise
of the Warrants is effective and a current prospectus relating to those Class A Ordinary Shares is available throughout the 30-day redemption
period. Any such exercise would not be on a cashless basis and would require the exercising warrant holder to pay the exercise price for
each Warrant being exercised.
Redemption of Warrants when the price per Class A
Ordinary Share equals or exceeds $10.00: Once the Warrants become exercisable, the Company may redeem the outstanding Warrants:
|
● |
in whole and not in part; |
|
● |
at a price of $0.10 per Warrant upon a minimum of 30 days’ prior written notice of redemption; provided that holders will be able to exercise their Warrants on a cashless basis prior to redemption and receive that number of shares determined by reference to the table set forth in the warrant agreement based on the redemption date and the “redemption fair market value” of Class A Ordinary Shares (as defined below) except as otherwise described in the warrant agreement; |
|
● |
if, and only if, the closing price of Class A Ordinary Shares equals or exceeds $10.00 per Public Share (as adjusted) for any 20 trading days within the 30-trading day period ending three trading days before the Company sends the notice of redemption to the warrant holders; and |
|
● |
if the closing price of the Class A Ordinary Shares for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders is less than $18.00 per share (as adjusted), the Private Placement Warrants must also be concurrently called for redemption on the same terms as the outstanding Public Warrants, as described above. |
Solely for the purposes of this redemption provision,
the “redemption fair market value” of the Company’s Class A Ordinary Shares shall mean the volume weighted average price
of the Class A Ordinary Shares for the ten (10) trading days immediately following the date on which notice of redemption is sent to the
holders of Warrants.
No fractional Class A Ordinary Shares issued upon
redemption. If, upon redemption, a holder would be entitled to receive a fractional interest in a share, the Company will round down to
the nearest whole number of the number of Class A Ordinary Shares to be issued to the holder.
Note 8 – Shareholder’s Deficit
Preference Shares – The
Company is authorized to issue 1,000,000 preference shares, par value $0.0001 per share, with such designations, voting and other rights
and preferences as may be determined from time to time by the Company’s board of directors. As of September 30, 2023 and December
31, 2022, there were no preference shares issued or outstanding.
Class A Ordinary Shares –
The Company is authorized to issue 200,000,000 Class A Ordinary Shares with a par value of $0.0001 per share. As of September 30, 2023
and December 31, 2022, there were 16,880,481 and 23,000,000 shares, respectively, of Class A Ordinary Shares issued and outstanding that
are subject to possible redemption.
Class B Ordinary Shares –
The Company is authorized to issue 20,000,000 Class B ordinary shares with a par value of $0.0001 per share. As of September 30, 2023
and December 31, 2022, 5,750,000 Class B ordinary shares were issued and outstanding.
Holders of the Class A Ordinary Shares and holders
of the Class B ordinary shares will vote together as a single class on all matters submitted to a vote of the Company’s shareholders,
except as required by law or stock exchange rule; provided that only holders of the Class B ordinary shares shall have the right
to vote on the appointment and removal of the Company’s directors prior to the Initial Business Combination or continuing the Company
in a jurisdiction outside the Cayman Islands (including any special resolution required to amend the constitutional documents of the Company
or to adopt new constitutional documents of the Company, in each case, as a result of the Company approving a transfer by way of continuation
in a jurisdiction outside the Cayman Islands).
Note 9 – Fair Value Measurements
The following table presents information about
the Company’s assets and liabilities that are measured at fair value on a recurring basis as of September 30, 2023.
| |
Level 1 | | |
Level 2 | | |
Level 3 | | |
Total | |
Assets | |
| | |
| | |
| | |
| |
Marketable securities held in Trust Account | |
$ | 183,950,121 | | |
$ | — | | |
$ | — | | |
$ | 183,950,121 | |
| |
$ | 183,950,121 | | |
$ | — | | |
$ | — | | |
$ | 183,950,121 | |
Liabilities | |
| | | |
| | | |
| | | |
| | |
Public Warrants | |
$ | 690,000 | | |
$ | — | | |
$ | — | | |
$ | 690,000 | |
Private Placement Warrants | |
| — | | |
| 870,000 | | |
| — | | |
| 870,000 | |
Total liabilities | |
$ | 690,000 | | |
$ | 870,000 | | |
$ | — | | |
$ | 1,560,000 | |
The following table presents information about
the Company’s assets and liabilities that are measured at fair value on a recurring basis as of December 31, 2022, including the
fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value.
| |
Level 1 | | |
Level 2 | | |
Level 3 | | |
Total | |
Assets | |
| | |
| | |
| | |
| |
Investments held in Trust Account | |
$ | 240,311,986 | | |
$ | — | | |
$ | — | | |
$ | 240,311,986 | |
Total assets | |
$ | 240,311,986 | | |
$ | — | | |
$ | — | | |
$ | 240,311,986 | |
| |
| | | |
| | | |
| | | |
| | |
Liabilities | |
| | | |
| | | |
| | | |
| | |
Public Warrants | |
$ | 1,035,000 | | |
$ | — | | |
$ | — | | |
$ | 1,035,000 | |
Private Placement Warrants | |
$ | — | | |
$ | 1,305,000 | | |
| — | | |
| 1,305,000 | |
Total liabilities | |
$ | 1,035,000 | | |
$ | 1,305,000 | | |
$ | — | | |
$ | 2,340,000 | |
The Warrants are accounted for as liabilities
pursuant to ASC 815-40 and are measured at fair value as of each reporting date. Changes in the fair value of the Warrants are recorded
in the statements of operations each period.
Transfers to/from Levels 1, 2, and 3 are recognized
at the end of the reporting period. During the quarter ended September 30, 2023 there were no transfers to/from any level. During the
year ended December 31, 2022, the public and private warrants were transferred out of level 3 into level 1 and level 2, respectively.
See the table below to illustrate the transfers out of level 3.
Level 3 warrant liabilities at January 1, 2022 | |
$ | — | |
Addition at March 14, 2022 | |
| 9,400,500 | |
Change in fair value of warrant liabilities | |
| (7,060,500 | ) |
Transfers from level 3 to level 2 instruments | |
| (1,305,000 | ) |
Transfers from level 3 to level 1 instruments | |
| (1,035,000 | ) |
Level 3 warrant liabilities at December 31, 2022 | |
$ | — | |
The fair value of the Public Warrants issued in
connection with the Initial Public Offering and Private Placement Warrants were initially measured at fair value using a Monte Carlo simulation
model. The fair value of Public Warrants issued in connection with the Initial Public Offering was measured based on the listed market
price of such warrants, a Level 1 measurement, since May 4, 2022. The fair value of the Private Placement Warrants has subsequently been
measured by reference to the trading price of the Public Warrants, which is considered to be a Level 2 fair value measurement. The Company
recognized change in the fair value of warrant liabilities of $353,600 and $780,000, which are presented as changes in fair value of derivative
warrant liabilities on the accompanying unaudited condensed statements of operations for the three and nine months ended September 30,
2023, respectively. The Company recognized a change in the fair value of warrant liabilities of $7,060,500, which is presented as change
in fair value of derivative warrant liabilities on the statements of operations for the year ended December 31, 2022.
The following table provides quantitative information
regarding Level 3 fair value measurement inputs for the Public Warrants and Private Placement Warrants at their measurement date:
| |
March 14, 2022 | |
| |
(IPO date) | |
Exercise Price | |
$ | 11.50 | |
Underlying share price | |
$ | 9.82 | |
Volatility | |
| 5.4 | % |
Term to Business Combination (years) | |
| 6.05 | |
Risk-free rate | |
| 2.13 | % |
The table below shows the change in fair value
of the derivative warrant liabilities as of September 30, 2023:
| |
Private Warrant | | |
Public Warrant | | |
Total | |
Fair value at January 1, 2023 | |
$ | 1,305,000 | | |
$ | 1,035,000 | | |
$ | 2,340,000 | |
Change in fair value | |
| (435,000 | ) | |
| (345,00 | ) | |
| (780,000 | ) |
Fair value as of September 30, 2023 | |
$ | 870,000 | | |
$ | 690,000 | | |
$ | 1,560,000 | |
The table below shows the change in fair value
of the derivative warrant liabilities as of September 30, 2022:
| |
Private Warrant | | |
Public Warrant | | |
Total | |
Fair value at January 1, 2022 | |
$ | — | | |
$ | — | | |
$ | — | |
Fair value at March 14, 2022 | |
| 4,151,500 | | |
| 5,249,000 | | |
| 9,400,500 | |
Change in fair value | |
| 2,081,500 | | |
| 2,639,000 | | |
| 4,720,500 | |
Fair value as of September 30, 2022 | |
$ | 2,070,000 | | |
$ | 2,610,000 | | |
$ | 4,680,000 | |
Item 2. Management’s Discussion and Analysis of Financial
Condition and Results of Operations.
References in this report (the “Quarterly
Report”) to “we,” “us” or the “Company” refer to Patria Latin American Opportunity Acquisition
Corp. References to our “management” or our “management team” refer to our officers and directors, references
to the “Sponsor” refer to Patria SPAC LLC. The following discussion and analysis of the Company’s financial condition
and results of operations should be read in conjunction with the unaudited condensed financial statements and the notes thereto contained
elsewhere in this Quarterly Report. Certain information contained in the discussion and analysis set forth below includes forward-looking
statements that involve risks and uncertainties.
Special Note Regarding Forward-Looking Statements
This Quarterly Report includes “forward-looking
statements” within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”) and Section
21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) that are not historical facts, and involve risks
and uncertainties that could cause actual results to differ materially from those expected and projected. All statements, other than statements
of historical fact included in this Form 10-Q including, without limitation, statements in this “Management’s Discussion and
Analysis of Financial Condition and Results of Operations” regarding the Company’s financial position, business strategy and
the plans and objectives of management for future operations, are forward-looking statements. Words such as “expect,” “believe,”
“anticipate,” “intend,” “estimate,” “seek” and variations and similar words and expressions
are intended to identify such forward-looking statements. Such forward-looking statements relate to future events or future performance,
but reflect management’s current beliefs, based on information currently available. A number of factors could cause actual events,
performance or results to differ materially from the events, performance and results discussed in the forward-looking statements. For
information identifying important factors that could cause actual results to differ materially from those anticipated in the forward-looking
statements, please refer to the Risk Factors section of the Company’s final prospectus for its Initial Public Offering filed with
the U.S. Securities and Exchange Commission (the “SEC”). The Company’s securities filings can be accessed on the EDGAR
section of the SEC’s website at www.sec.gov. Except as expressly required by applicable securities law, the Company disclaims any
intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.
Overview
We are a blank check company incorporated in Cayman
Islands on February 25, 2021. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition,
ordinary share purchase, reorganization or similar business combination with one or more businesses, or the “Business Combination.”
The Company is an emerging growth company and, as such, the Company is subject to all of the risks associated with emerging growth companies.
Initial Business Combination
The Company’s management has broad discretion
with respect to the specific application of the net proceeds of the IPO, although substantially all of the net proceeds are intended to
be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business
Combination successfully. The Company must complete one or more initial Business Combinations having an aggregate fair market value of
at least 80% of the net assets held in the Trust Account (as defined below) (excluding the amount of deferred underwriting commission
held in Trust and taxes payable on the income earned on the Trust Account) at the time of the agreement to enter into the initial Business
Combination. However, the Company only intends to complete a Business Combination if the post-business combination company owns or acquires
50% or more of the issued and outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient
for it not to be required to register as an investment company under the Investment Company Act 1940, as amended (the “Investment
Company Act”). Upon the closing of the IPO, management has agreed that an amount equal to at least $10.30 per Unit sold in the IPO,
including the proceeds from the sale of the Private Placement Warrants, will be held in a trust account (“Trust Account”)
located in the United States with Continental Stock Transfer & Trust Company acting as trustee, and invested only in United States
“government securities” within the meaning of Section 2(a)(16) of the Investment Company Act having a maturity of 185 days
or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act which invest
only in direct U.S. government treasury obligations, as determined by the Company, until the earlier of: (i) the completion of a Business
Combination and (ii) the distribution of the Trust Account as described below. The Company will provide the holders (the “Public
Shareholders”) of the Company’s issued and outstanding Class A ordinary shares, par value $0.0001 per share, sold in the IPO
(the “Public Shares”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business
Combination either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender
offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will
be made by the Public Shares for a pro rata portion of the amount then held in the Trust Account. The per-share amount to be distributed
to Public Shareholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay
to the underwriters. If the Company seeks shareholder approval, the Company will proceed with a Business Combination if a majority of
the shares voted are voted in favor of the Business Combination. If a shareholder vote is not required by law and the Company does not
decide to hold a shareholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Articles
of Association (the “Articles of Association”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities
and Exchange Commission (“SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If,
however, shareholder approval of the transaction is required by law, or the Company decides to obtain shareholder approval for business
or legal reasons, the Company will offer to redeem the Public Shares in conjunction with a proxy solicitation pursuant to the proxy rules
and not pursuant to the tender offer rules. Additionally, each Public Shareholder may elect to redeem their Public Shares irrespective
of whether they vote for or against the proposed transaction. If the Company seeks shareholder approval in connection with a Business
Combination, the initial shareholders (as defined below) have agreed to vote their Founder Shares (as defined below) and any Public Shares
purchased during or after the IPO in favor of a Business Combination. In addition, the initial shareholders have agreed to waive their
redemption rights with respect to their Founder Shares and Public Shares in connection with the completion of a Business Combination.
The Articles of Association will provide that
a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert
or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)),
will be restricted from redeeming its shares with respect to more than an aggregate of 15% of the Public Shares, without the prior consent
of the Company. The holders of the Founder Shares (the “initial shareholders”) have agreed not to propose an amendment to
the Articles of Association (A) to modify the substance or timing of the Company’s obligation to allow redemption in connection
with a Business Combination or to redeem 100% of the Public Shares if the Company does not complete a Business Combination within the
Combination Period (as defined below) or (B) with respect to any other provision relating to shareholders’ rights or pre-initial
Business Combination activity, unless the Company provides the Public Shareholders with the opportunity to redeem their Public Shares
in conjunction with any such amendment.
If the Company is unable to complete a Business
Combination within 15 months from the closing of the IPO (or up to within 21 months if the Company extends the period of time to consummate
the Initial Business Combination in accordance with the terms described in the Company’s final prospectus) of the IPO (the “Combination
Period”) and the Company’s shareholders have not amended the Articles of Association to extend such Combination Period, the
Company will (i) cease all operations except for the purpose of winding up; (ii) as promptly as reasonably possible but no more than ten
business days thereafter subject to lawfully available funds therefor, redeem the Public Shares, at a per-share price, payable in cash,
equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and
not previously released to the Company to pay its taxes, if any (less up to $100,000 of interest to pay dissolution expenses) divided
by the number of the then outstanding Public Shares, which redemption will completely extinguish Public Shareholders’ rights as
shareholders (including the right to receive further liquidation distributions, if any), subject to applicable law; and (iii) as promptly
as reasonably possible following such redemption, subject to the approval of the remaining shareholders and the board of directors, liquidate
and dissolve, subject in each case to the Company’s obligations under Cayman law to provide for claims of creditors and the requirements
of other applicable law.
The initial shareholders have agreed to waive
their rights to liquidating distributions from the Trust Account with respect to the Founder Shares if the Company fails to complete a
Business Combination within the Combination Period. However, if the initial shareholders acquire Public Shares after the IPO, they will
be entitled to liquidating distributions from the Trust if the Company fails to complete a Business Combination within the Combination
Period. The underwriters have agreed to waive their rights to the deferred underwriting commission held in the Trust Account in the event
the Company does not complete a Business Combination within in the Combination Period and, in such event, such amounts will be included
with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such
distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account
assets) will be only $10.30. In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company
if and to the extent any claims by a third party (except for the Company’s independent registered public accounting firm) for services
rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction
agreement (a “Target”), reduce the amount of funds in the Trust Account to below (i) $10.30 per unit or (ii) the lesser amount
per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of the
trust assets, in each case net of interest which may be withdrawn to pay taxes, provided that such liability will not apply to any claims
by a third party or Target that executed a waiver of any and all rights to seek access to the Trust Account nor will it apply to any claims
under the Company’s indemnity of the underwriters of the IPO against certain liabilities, including liabilities under the Securities
Act of 1933, as amended (the “Securities Act”). In the event that an executed waiver is deemed to be unenforceable against
a third party, our sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to
reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all
vendors, service providers (other than the Company’s independent registered public accounting firm), prospective target businesses
or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim
of any kind in or to monies held in the Trust Account.
Results of Operations
We have neither engaged in any operations nor
generated any revenues to date. Our only activities from February 25, 2021 (inception) through September 30, 2023 were organizational
activities, those necessary to prepare for the Initial Public Offering, described below, and the Company’s search for a target business
with which to complete a Business Combination. We do not expect to generate any operating revenues until after the completion of our initial
Business Combination. We generate non-operating income in the form of realized gains on the investments held in the trust account. We
are incurring expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as
well as for due diligence expenses in connection with completing a Business Combination.
For the nine months ended September 30, 2023 we
reported net income of $7,453,331 which consists of general and administrative expenses of $928,551 (made up of professional services
fees of $442,116 and other general and administrative fees of $486,435), change in fair value of derivative warrant liabilities of $780,000
and realized gain on the investments held in the trust account of $7,601,882.
For the nine months ended September 30, 2022 we
reported net income of $5,080,880 which consists of general and administrative expenses of $728,577 (made up of professional services
fees of $305,111 and other general and administrative fees of $423,466), change in fair value of derivative warrant liabilities of $4,720,500
gain on the investments held in the Trust Account of $1,403,465 and transaction costs allocated to derivative warrant liabilities of $314,508.
For the three months ended September 30, 2023
we reported net income of $1,766,214 which consists of general and administrative expenses of $241,063 (made up of professional services
fees of $75,095 and other general and administrative fees of $165,968), change in fair value of derivative warrant liabilities of $(353,600)
and realized gain on the investments held in the trust account of $2,360,877.
For the three months ended September 30, 2022
we reported net loss of $(438,683) which consists of general and administrative expenses of $240,538 (made up of professional services
fees of $145,488, and other general and administrative fees of $95,050), change in fair value of derivative warrant liabilities of $(1,300,000),
gain on the investments held in the Trust Account of $1,101,855 and transaction costs allocated to derivative warrant liabilities of $0.
Liquidity and Going Concern Consideration
As of September 30, 2023, the Company had working
capital of $173,155,304 including the Trust Account, deferred underwriting fees payable. Working capital was $(1,184,817) when marketable
securities held in Trust Account, deferred underwriting fees payable, and derivative warrant liabilities were excluded from the calculation.
Of the net proceeds from the IPO and associated sale of Private Placement Warrants, $236,900,000 of cash was placed in the Trust Account.
The working capital surplus includes the amount of restricted marketable securities held in the Trust Account, deferred underwriting fees
payable and derivative warrant liabilities, all of which have been classified as current at September 30, 2023 as a result of the Company
being less than 12 months away from consuming the assets held in the Trust Account to either consummate a business combination or to liquidate.
For the nine months ended September 30, 2023,
cash used in operating activities was $522,362, which is made up of a net income of $7,453,331, changes in operating assets and liabilities
of $406,189. These amounts were offset by a gain on Investments held in the Trust account of $7,601,882 and change in fair value of derivative
warrant liabilities of $780,000. Cash of $182,243 was held outside of the Trust Account and is available for the Company’s working
capital purposes.
As of September 30, 2023, we had cash of $182,243.
We intend to use the funds held outside the Trust Account primarily to identify and evaluate target businesses, perform business due diligence
on prospective target businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their
representatives or owners, review corporate documents and material agreements of prospective target businesses, structure, negotiate and
complete a Business Combination.
In order to finance transaction costs in connection
with an Initial Business Combination, the Company’s sponsor, or an affiliate of the sponsor or certain of the Company’s officers
and directors may, but are not obligated to, provide Working Capital Loans to the Company. As of September 30, 2023, there were no amounts
outstanding under any Working Capital Loans.
If the Company’s estimates of the costs
of identifying a target business, undertaking due diligence and negotiating an Initial Business Combination are less than the actual amount
necessary to do so, the Company may have insufficient funds available to operate its business prior to an Initial Business Combination.
Moreover, the Company may need to obtain additional financing either to complete an Initial Business Combination or because it becomes
obligated to redeem a significant number of its Public Shares upon completion of an Initial Business Combination, in which case the Company
may issue additional securities or incur debt in connection with such Initial Business Combination.
The Company anticipates that the cash held outside
of the Trust Account as of September 30, 2023 will not be sufficient to allow the Company to operate for at least the next 12 months from
the issuance of the unaudited condensed financial statements, assuming that a Business Combination is not consummated during that time.
Over this time period, the Company will be using the funds held outside of the Trust Account for paying existing accounts payable and
accrued liabilities, identifying and evaluating prospective initial Business Combination candidates, performing due diligence on prospective
target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating
and consummating the Business Combination. These conditions raise substantial doubt about the Company’s ability to continue as a
going concern for a period of time within one year after the date that the unaudited condensed financial statements are issued. Management
plans to address this uncertainty through the Business Combination as discussed above. In addition, the sponsor or an affiliate of the
sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required
under the Working Capital Loans. There is no assurance that the Company’s plans to consummate the Business Combination will be successful
or successful within the Combination Period or that the sponsor or an affiliate of the sponsor, or certain of the Company’s officers
and directors will loan the Company funds as may be required under the Working Capital Loans.
The unaudited condensed financial statements do
not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary
should the Company be unable to continue as a going concern.
Commitments and Contractual Obligations
We do not have any long-term debt, capital lease
obligations, operating lease obligations or long-term liabilities.
The underwriters are entitled to a deferred fee
of $0.35 per Unit, or $8,050,000 in the aggregate. The deferred fee will be waived by the underwriters in the event that the Company does
not complete a Business Combination, subject to the terms of the underwriting agreement.
Administrative Services Agreement
Following our IPO, the Company pays the Sponsor
or an affiliate a monthly fee of $10,000 for office space, utilities, secretarial and administrative services. In August 2023, the Company
and its Sponsor executed an agreement to discontinue the remittance of administrative fees to the Sponsor with an effective date of August
1, 2023.For the three and nine months ended September 30, 2023, we incurred and paid $0 and $60,000 in administrative support fees. For
the three and nine months ended September 30, 2022, we incurred and paid $30,000 and $65,484 in administrative support fees.
Registration Rights
The holders of Founder Shares and Private Placement
Warrants, including any that may be issued upon conversion of Working Capital Loans, if any (and any Class A ordinary shares issuable
upon the exercise of the Private Placement Warrants, including any that may be issued upon conversion of the Working Capital Loans), will
be entitled to registration rights pursuant to a registration rights agreement entered into prior to the consummation of the IPO. These
holders will be entitled to certain demand and “piggyback” registration rights. However, the registration rights agreement
provides that the Company is not required to effect or permit any registration or cause any registration statement to become effective
until termination of the applicable lock-up period. The Company will bear the expenses incurred in connection with the filing of any such
registration statements.
Critical Accounting Estimates
The preparation of the unaudited condensed financial
statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires
management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets
and liabilities at the date of the unaudited condensed financial statements, and income and expenses during the periods reported. Actual
results could materially differ from those estimates. We have not identified any critical accounting estimates.
Recent Accounting Standards
See “Recent Accounting Pronouncements”
in Note 2 of the accompanying unaudited condensed financial statements.
JOBS Act
The Jumpstart Our Business Startups Act of 2012
(the “JOBS Act”) contains provisions that, among other things, relax certain reporting requirements for qualifying public
companies. We qualify as an “emerging growth company” and under the JOBS Act are allowed to comply with new or revised accounting
pronouncements based on the effective date for private (not publicly traded) companies. We are electing to delay the adoption of new or
revised accounting standards, and as a result, we may not comply with new or revised accounting standards on the relevant dates on which
adoption of such standards is required for non-emerging growth companies. As a result, the unaudited condensed financial statements may
not be comparable to companies that comply with new or revised accounting pronouncements as of public company effective dates.
Additionally, we are in the process of evaluating
the benefits of relying on the other reduced reporting requirements provided by the JOBS Act. Subject to certain conditions set forth
in the JOBS Act, if, as an “emerging growth company,” we choose to rely on such exemptions we may not be required to, among
other things, (i) provide an auditor’s attestation report on our system of internal controls over financial reporting pursuant to
Section 404, (ii) provide all of the compensation disclosure that may be required of non-emerging growth public companies under the Dodd-Frank
Wall Street Reform and Consumer Protection Act, (iii) comply with any requirement that may be adopted by the PCAOB regarding mandatory
audit firm rotation or a supplement to the auditor’s report providing additional information about the audit and the unaudited condensed
financial statements (auditor discussion and analysis) and (iv) disclose certain executive compensation related items such as the correlation
between executive compensation and performance and comparisons of the CEO’s compensation to median employee compensation. These
exemptions will apply for a period of five years following the completion of our Initial Public Offering or until we are no longer an
“emerging growth company,” whichever is earlier.
Item 3. Quantitative and Qualitative Disclosures About Market
Risk.
We are a smaller reporting company as defined
by Rule 12b-2 of the Exchange Act and are not required to provide the information otherwise required under this item.
Item 4. Controls and Procedures.
Evaluation of Disclosure Controls and Procedures
Disclosure controls are procedures that are designed
with the objective of ensuring that information required to be disclosed in our reports filed under the Exchange Act, such as this Report,
is recorded, processed, summarized, and reported within the time period specified in the SEC’s rules and forms. Disclosure controls
are also designed with the objective of ensuring that such information is accumulated and communicated to our management, including the
chief executive officer and chief financial officer, as appropriate to allow timely decisions regarding required disclosure. Our management
evaluated, with the participation of our current chief executive officer and chief financial officer (our “Certifying Officers”),
the effectiveness of our disclosure controls and procedures as of September 30, 2023, pursuant to Rule 13a-15(b) under the Exchange Act.
Based upon that evaluation, our Certifying Officers concluded that, as of September 30, 2023, our disclosure controls and procedures were
effective.
We do not expect that our disclosure controls
and procedures will prevent all errors and all instances of fraud. Disclosure controls and procedures, no matter how well conceived and
operated, can provide only reasonable, not absolute, assurance that the objectives of the disclosure controls and procedures are met.
Further, the design of disclosure controls and procedures must reflect the fact that there are resource constraints, and the benefits
must be considered relative to their costs. Because of the inherent limitations in all disclosure controls and procedures, no evaluation
of disclosure controls and procedures can provide absolute assurance that we have detected all our control deficiencies and instances
of fraud, if any. The design of disclosure controls and procedures also is based partly on certain assumptions about the likelihood of
future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.
Changes in Internal Control over Financial Reporting
There were no changes in our internal control
over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) during the most recent fiscal
quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
PART II - OTHER INFORMATION
Item 1. Legal Proceedings
None.
Item 1A. Risk Factors
Factors that could cause our actual results to
differ materially from those in this report include the risk factors described in in the Company’s annual report on Form 10-K as
filed with the SEC on March 31, 2023. As of the date of this Report, there have been no material changes to the risk factors disclosed
in our final prospectus filed with the SEC other than the additional risk factor set forth in our quarterly report on Form 10-Q filed
with the SEC on May 5, 2022.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
On March 14, 2022, we consummated the Initial
Public Offering of 23,000,000 Units, including 3,000,000 Units sold pursuant to the full exercise of the underwriters’ option to
purchase additional Units to cover over-allotments. The Units sold were sold at an offering price of $10.00 per unit, generating total
gross proceeds of $230,000,000. JP Morgan Securities LLC and Citigroup Global Markets Inc. JP Morgan Securities LLC and Citigroup Global
Markets Inc. acted as joint book-running managers for the offering. The securities in the offering were registered under the Securities
Act on a registration statement on Form S-1 (No. 333-254498). The Securities and Exchange Commission declared the registration statement
effective on March 9, 2022.
Simultaneously with the consummation of the Initial
Public Offering and the full exercise of the over-allotment option, we consummated the private placement of an aggregate of 14,500,000
warrants at a price of $1.00 per Private Placement Warrant, generating total proceeds of $14,500,000 The issuance was made pursuant to
the exemption from registration contained in Section 4(a)(2) of the Securities Act.
The Private Placement Warrants are identical to
the warrants underlying the Units sold in the Initial Public Offering, except that the Private Placement Warrants are not transferable,
assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions.
Of the gross proceeds received from the Initial
Public Offering, the full exercise of the over-allotment option and the sale of the Private Placement Warrants, $236,900,000 was placed
in the Trust Account.
We accrued a total of $13,779,665 in transaction
costs, including $8,050,000 in deferred underwriting fees, $4,600,000 in upfront underwriting fees, and other offering costs of $1,129,665
related to the Initial Public Offering.
For a description of the use of the proceeds generated
in our Initial Public Offering, see Part I, Item 2 of this Quarterly Report.
Item 3. Defaults Upon Senior Securities
None.
Item 4. Mine Safety Disclosures
Not Applicable
Item 5. Other Information
None.
Item 6.
Exhibits
** |
These certifications are furnished to the SEC pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and are deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing. |
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
PATRIA LATIN AMERICAN OPPORTUNITY ACQUISITION CORP. |
|
|
|
|
Date: November 13, 2023 |
By: |
/s/ José Augusto Gonçalves de Araújo Teixeira |
|
|
Name: |
José Augusto Gonçalves de Araújo Teixeira |
|
|
Title: |
Chief Executive Officer |
30
00-0000000
KY
16880481
16934066
20511844
23000000
0.01
0.13
0.38
0.65
5552198
5750000
5750000
5750000
0.05
0.05
0.07
1.06
16880481
23000000
5750000
5750000
0.01
0.05
0.07
0.13
16934066
20511844
5552198
5750000
0.05
0.38
0.65
1.06
12000000
34500
false
--12-31
Q3
0001849737
0001849737
2023-01-01
2023-09-30
0001849737
plao:UnitsEachConsistingOfOneClassAOrdinaryShare00001ParValueAndOnehalfOfOneRedeemableWarrantMember
2023-01-01
2023-09-30
0001849737
plao:ClassAOrdinarySharesIncludedAsPartOfTheUnitsMember
2023-01-01
2023-09-30
0001849737
plao:RedeemableWarrantsIncludedAsPartOfTheUnitsEachWholeWarrantExercisableForOneClassAOrdinaryShareAtAnExercisePriceOf1150Member
2023-01-01
2023-09-30
0001849737
us-gaap:CommonClassAMember
2023-11-13
0001849737
us-gaap:CommonClassBMember
2023-11-13
0001849737
2023-09-30
0001849737
2022-12-31
0001849737
us-gaap:RelatedPartyMember
2023-09-30
0001849737
us-gaap:RelatedPartyMember
2022-12-31
0001849737
us-gaap:CommonClassAMember
2023-09-30
0001849737
us-gaap:CommonClassAMember
2022-12-31
0001849737
us-gaap:CommonClassBMember
2023-09-30
0001849737
us-gaap:CommonClassBMember
2022-12-31
0001849737
2023-07-01
2023-09-30
0001849737
2022-07-01
2022-09-30
0001849737
2022-01-01
2022-09-30
0001849737
us-gaap:CommonClassAMember
2023-07-01
2023-09-30
0001849737
us-gaap:CommonClassAMember
2022-07-01
2022-09-30
0001849737
us-gaap:CommonClassAMember
2023-01-01
2023-09-30
0001849737
us-gaap:CommonClassAMember
2022-01-01
2022-09-30
0001849737
us-gaap:CommonClassBMember
2023-07-01
2023-09-30
0001849737
us-gaap:CommonClassBMember
2022-07-01
2022-09-30
0001849737
us-gaap:CommonClassBMember
2023-01-01
2023-09-30
0001849737
us-gaap:CommonClassBMember
2022-01-01
2022-09-30
0001849737
us-gaap:CommonClassAMember
plao:OrdinarySharesSubjectToPossibleRedemptionMember
2022-12-31
0001849737
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2022-12-31
0001849737
us-gaap:AdditionalPaidInCapitalMember
2022-12-31
0001849737
us-gaap:RetainedEarningsMember
2022-12-31
0001849737
us-gaap:CommonClassAMember
plao:OrdinarySharesSubjectToPossibleRedemptionMember
2023-01-01
2023-03-31
0001849737
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2023-01-01
2023-03-31
0001849737
us-gaap:AdditionalPaidInCapitalMember
2023-01-01
2023-03-31
0001849737
us-gaap:RetainedEarningsMember
2023-01-01
2023-03-31
0001849737
2023-01-01
2023-03-31
0001849737
us-gaap:CommonClassAMember
plao:OrdinarySharesSubjectToPossibleRedemptionMember
2023-03-31
0001849737
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2023-03-31
0001849737
us-gaap:AdditionalPaidInCapitalMember
2023-03-31
0001849737
us-gaap:RetainedEarningsMember
2023-03-31
0001849737
2023-03-31
0001849737
us-gaap:CommonClassAMember
plao:OrdinarySharesSubjectToPossibleRedemptionMember
2023-04-01
2023-06-30
0001849737
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2023-04-01
2023-06-30
0001849737
us-gaap:AdditionalPaidInCapitalMember
2023-04-01
2023-06-30
0001849737
us-gaap:RetainedEarningsMember
2023-04-01
2023-06-30
0001849737
2023-04-01
2023-06-30
0001849737
us-gaap:CommonClassAMember
plao:OrdinarySharesSubjectToPossibleRedemptionMember
2023-06-30
0001849737
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2023-06-30
0001849737
us-gaap:AdditionalPaidInCapitalMember
2023-06-30
0001849737
us-gaap:RetainedEarningsMember
2023-06-30
0001849737
2023-06-30
0001849737
us-gaap:CommonClassAMember
plao:OrdinarySharesSubjectToPossibleRedemptionMember
2023-07-01
2023-09-30
0001849737
us-gaap:RetainedEarningsMember
2023-07-01
2023-09-30
0001849737
us-gaap:CommonClassAMember
plao:OrdinarySharesSubjectToPossibleRedemptionMember
2023-09-30
0001849737
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2023-09-30
0001849737
us-gaap:RetainedEarningsMember
2023-09-30
0001849737
us-gaap:CommonClassAMember
plao:OrdinarySharesSubjectToPossibleRedemptionMember
2021-12-31
0001849737
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2021-12-31
0001849737
us-gaap:AdditionalPaidInCapitalMember
2021-12-31
0001849737
us-gaap:RetainedEarningsMember
2021-12-31
0001849737
2021-12-31
0001849737
us-gaap:CommonClassAMember
plao:OrdinarySharesSubjectToPossibleRedemptionMember
2022-01-01
2022-03-31
0001849737
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2022-01-01
2022-03-31
0001849737
us-gaap:AdditionalPaidInCapitalMember
2022-01-01
2022-03-31
0001849737
us-gaap:RetainedEarningsMember
2022-01-01
2022-03-31
0001849737
2022-01-01
2022-03-31
0001849737
us-gaap:CommonClassAMember
plao:OrdinarySharesSubjectToPossibleRedemptionMember
2022-03-31
0001849737
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2022-03-31
0001849737
us-gaap:AdditionalPaidInCapitalMember
2022-03-31
0001849737
us-gaap:RetainedEarningsMember
2022-03-31
0001849737
2022-03-31
0001849737
us-gaap:CommonClassAMember
plao:OrdinarySharesSubjectToPossibleRedemptionMember
2022-04-01
2022-06-30
0001849737
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2022-04-01
2022-06-30
0001849737
us-gaap:AdditionalPaidInCapitalMember
2022-04-01
2022-06-30
0001849737
us-gaap:RetainedEarningsMember
2022-04-01
2022-06-30
0001849737
2022-04-01
2022-06-30
0001849737
us-gaap:CommonClassAMember
plao:OrdinarySharesSubjectToPossibleRedemptionMember
2022-06-30
0001849737
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2022-06-30
0001849737
us-gaap:AdditionalPaidInCapitalMember
2022-06-30
0001849737
us-gaap:RetainedEarningsMember
2022-06-30
0001849737
2022-06-30
0001849737
us-gaap:CommonClassAMember
plao:OrdinarySharesSubjectToPossibleRedemptionMember
2022-07-01
2022-09-30
0001849737
us-gaap:RetainedEarningsMember
2022-07-01
2022-09-30
0001849737
us-gaap:CommonClassAMember
plao:OrdinarySharesSubjectToPossibleRedemptionMember
2022-09-30
0001849737
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2022-09-30
0001849737
us-gaap:RetainedEarningsMember
2022-09-30
0001849737
2022-09-30
0001849737
us-gaap:IPOMember
2022-03-14
2022-03-14
0001849737
us-gaap:OverAllotmentOptionMember
2022-03-14
2022-03-14
0001849737
us-gaap:CommonClassAMember
us-gaap:IPOMember
2022-03-14
0001849737
us-gaap:CommonClassAMember
2022-03-14
0001849737
2022-03-14
0001849737
us-gaap:CommonClassAMember
2022-03-14
2022-03-14
0001849737
us-gaap:PrivatePlacementMember
2023-09-30
0001849737
us-gaap:PrivatePlacementMember
2023-01-01
2023-09-30
0001849737
2022-03-14
2022-03-14
0001849737
us-gaap:IPOMember
2022-03-14
0001849737
us-gaap:PrivatePlacementMember
2022-03-14
2022-03-14
0001849737
us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember
2023-09-30
0001849737
us-gaap:CommonClassAMember
2023-06-14
2023-06-14
0001849737
2023-07-12
2023-07-12
0001849737
us-gaap:SubsequentEventMember
2023-10-01
2023-10-10
0001849737
us-gaap:SubsequentEventMember
2023-11-01
2023-11-13
0001849737
plao:InitialBusinessCombinationMember
2023-09-30
0001849737
us-gaap:IPOMember
2023-09-30
0001849737
plao:TrustAccountMember
2023-09-30
0001849737
2022-01-01
2022-12-31
0001849737
us-gaap:CommonClassAMember
2022-01-01
2022-12-31
0001849737
us-gaap:IPOMember
2023-01-01
2023-09-30
0001849737
us-gaap:OverAllotmentOptionMember
2023-01-01
2023-09-30
0001849737
us-gaap:CommonClassAMember
2023-06-12
2023-06-12
0001849737
2023-06-12
0001849737
us-gaap:CommonClassAMember
2023-06-12
0001849737
us-gaap:CommonClassBMember
2023-06-12
0001849737
plao:PrivatePlacementWarrantsMember
us-gaap:PrivatePlacementMember
2023-09-30
0001849737
plao:PrivatePlacementWarrantsMember
us-gaap:PrivatePlacementMember
2023-01-01
2023-09-30
0001849737
us-gaap:CommonClassAMember
us-gaap:PrivatePlacementMember
2023-09-30
0001849737
plao:FounderSharesMember
plao:SponsorMember
us-gaap:CommonClassBMember
2021-03-03
2021-03-03
0001849737
plao:FounderSharesMember
plao:SponsorMember
us-gaap:CommonClassBMember
2021-03-01
2021-03-03
0001849737
plao:FounderSharesMember
plao:SponsorMember
2022-02-28
0001849737
plao:FounderSharesMember
plao:SponsorMember
2022-02-01
2022-02-28
0001849737
plao:FounderSharesMember
plao:SponsorMember
2022-03-09
0001849737
plao:FounderSharesMember
2023-09-30
0001849737
plao:SponsorMember
us-gaap:CommonClassAMember
2023-09-30
0001849737
plao:FounderSharesMember
plao:SponsorMember
us-gaap:CommonClassAMember
2023-01-01
2023-09-30
0001849737
2021-03-03
0001849737
plao:PromissoryNoteRelatedPartyMember
2022-01-01
2022-01-31
0001849737
plao:PromissoryNoteRelatedPartyMember
2022-01-31
0001849737
us-gaap:RelatedPartyMember
plao:SponsorMember
2023-09-30
0001849737
2023-10-10
0001849737
plao:SponsorMember
2023-01-01
2023-09-30
0001849737
plao:AdministrativeSupportAgreementMember
2023-07-01
2023-09-30
0001849737
plao:AdministrativeSupportAgreementMember
2023-01-01
2023-09-30
0001849737
plao:AdministrativeSupportAgreementMember
2022-07-01
2022-09-30
0001849737
plao:AdministrativeSupportAgreementMember
2022-01-01
2022-09-30
0001849737
plao:WorkingCapitalLoansMember
2023-09-30
0001849737
plao:UnderwritingAgreementMember
2023-01-01
2023-09-30
0001849737
plao:PublicWarrantsMember
2023-09-30
0001849737
plao:PrivatePlacementWarrantsMember
2023-09-30
0001849737
us-gaap:CommonClassAMember
us-gaap:NoteWarrantMember
2023-09-30
0001849737
us-gaap:WarrantMember
2023-01-01
2023-09-30
0001849737
us-gaap:FairValueInputsLevel1Member
2023-09-30
0001849737
us-gaap:FairValueInputsLevel2Member
2023-09-30
0001849737
us-gaap:FairValueInputsLevel3Member
2023-09-30
0001849737
us-gaap:FairValueInputsLevel1Member
plao:PublicWarrantsMember
2023-09-30
0001849737
us-gaap:FairValueInputsLevel2Member
plao:PublicWarrantsMember
2023-09-30
0001849737
us-gaap:FairValueInputsLevel3Member
plao:PublicWarrantsMember
2023-09-30
0001849737
us-gaap:FairValueInputsLevel1Member
us-gaap:PrivatePlacementMember
2023-09-30
0001849737
us-gaap:FairValueInputsLevel2Member
us-gaap:PrivatePlacementMember
2023-09-30
0001849737
us-gaap:FairValueInputsLevel3Member
us-gaap:PrivatePlacementMember
2023-09-30
0001849737
us-gaap:FairValueInputsLevel1Member
2023-01-01
2023-09-30
0001849737
us-gaap:FairValueInputsLevel2Member
2023-01-01
2023-09-30
0001849737
us-gaap:FairValueInputsLevel3Member
2023-01-01
2023-09-30
0001849737
us-gaap:FairValueInputsLevel1Member
2022-12-31
0001849737
us-gaap:FairValueInputsLevel2Member
2022-12-31
0001849737
us-gaap:FairValueInputsLevel3Member
2022-12-31
0001849737
us-gaap:FairValueInputsLevel1Member
plao:PublicWarrantsMember
2022-12-31
0001849737
us-gaap:FairValueInputsLevel2Member
plao:PublicWarrantsMember
2022-12-31
0001849737
us-gaap:FairValueInputsLevel3Member
plao:PublicWarrantsMember
2022-12-31
0001849737
plao:PublicWarrantsMember
2022-12-31
0001849737
us-gaap:FairValueInputsLevel1Member
us-gaap:PrivatePlacementMember
2022-12-31
0001849737
us-gaap:FairValueInputsLevel2Member
us-gaap:PrivatePlacementMember
2022-12-31
0001849737
us-gaap:FairValueInputsLevel3Member
us-gaap:PrivatePlacementMember
2022-12-31
0001849737
us-gaap:PrivatePlacementMember
2022-12-31
0001849737
us-gaap:FairValueInputsLevel1Member
2022-01-01
2022-12-31
0001849737
us-gaap:FairValueInputsLevel2Member
2022-01-01
2022-12-31
0001849737
us-gaap:FairValueInputsLevel3Member
2022-01-01
2022-12-31
0001849737
2022-03-14
2022-12-31
0001849737
plao:TransfersFromLevel3ToLevel2InstrumentsMember
2022-12-31
0001849737
plao:TransfersFromLevel3ToLevel1InstrumentsMember
2022-12-31
0001849737
plao:PublicWarrantsMember
2023-01-01
2023-09-30
0001849737
us-gaap:PrivatePlacementMember
2021-12-31
0001849737
plao:PublicWarrantsMember
2021-12-31
0001849737
us-gaap:PrivatePlacementMember
2022-03-14
2022-09-30
0001849737
plao:PublicWarrantsMember
2022-03-14
2022-09-30
0001849737
2022-03-14
2022-09-30
0001849737
us-gaap:PrivatePlacementMember
2022-09-30
0001849737
plao:PublicWarrantsMember
2022-09-30
xbrli:shares
iso4217:USD
iso4217:USD
xbrli:shares
xbrli:pure
In connection with the Quarterly Report of Patria Latin American Opportunity
Acquisition Corp. (the “Company”) on Form 10-Q for the quarter ended September 30, 2023, as filed with the Securities and
Exchange Commission on the date hereof (the “Report”), I, José Augusto Gonçalves de Araújo Teixeira,
Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002, that, to my knowledge:
In connection with the Quarterly Report of Patria Latin American Opportunity
Acquisition Corp. (the “Company”) on Form 10-Q for the quarter ended September 30, 2023, as filed with the Securities and
Exchange Commission on the date hereof (the “Report”), I, Ana Cristina Russo, Chief Financial Officer of the Company, certify,
pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge: